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TITLE OF THE ABSTRACT: Low dose Succinylcholine to facilitate Laryngeal Mask Airway 
insertion 
DEPARTMENT: Anaesthesiology 
NAME OF THE CANDIDATE: Dr. Leah Maria Raju 
DEGREE AND  SUBJECT: MD, Anaesthesiology 
NAME OF THE GUIDE: Dr Sarah Ninan 
OBJECTIVES:  
1) To prove that low dose Succinylcholine facilitates Laryngeal Mask Airway insertion. 
2) To ascertain the lowest acceptable dose of Succinylcholine that is needed for smooth LMA insertion. 
 
3)  To ascertain if use of Succinylcholine, decreases Propofol consumption. 
 
4) To compare haemodynamics, in the three groups.  
 
METHODS: clinical and statistical 
 
This is a prospective, double blinded, randomized control trial of 283 patients randomized into three  
 
groups- placebo, 0.1mg/kg and 0.25mg/kg of Succinylcholine. Patients excluded were ASA > II, age <  
 
20 or > 65, BMI > 30, oral surgeries and difficult airways. Patients were induced with 2mg/kg of  
 
Propofol, after 2μgms/kg of Fentanyl. The study drug was given. After 60 seconds a classic LMA was  
 
inserted by the standard method by a single investigator. Jaw relaxation, coughing, gagging, movement,  
 
laryngospasm, ease of insertion, number of attempts, Propofol usage and haemodynamics were assessed.  
 
Statistical methods used were ANOVA with Bonferroni’s t test, chi square test and Fischer’s test. p value  
 
<0.05 was considered statistically significant. 
 
RESULTS: 
 
There was equal distribution of patients in all three groups. Demographically age, weight, height and  
 
BMI were equally distributed, though males were more than females. Jaw relaxation was significantly  
 
better in the 0.25mg/ kg Succinylcholine group. There was no significant difference in coughing and  
 
gagging in the groups, but patient movement was more in the Placebo group. Two patients in the placebo  
 
group experienced partial laryngospasm. Overall insertion conditions were significantly better in the  
 
0.25mg/kg group compared to the other two groups. Propofol consumption was significantly more in the  
 
placebo group. The study concludes that 0.25 mg/kg Succinylcholine facilitates insertion of the   
 
Laryngeal Mask Airway. 
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AIM 
 
The aim of this study is to prove that low dose Succinylcholine facilitates Laryngeal Mask 
Airway insertion.  
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OBJECTIVES 
1) To prove that low dose Succinylcholine facilitates Laryngeal Mask Airway insertion, leading  
to lesser attempts at insertion. 
2) To ascertain the lowest acceptable dose of Succinylcholine that is needed for smooth LMA insertion, 
 
 avoiding its side effects. Comparing placebo, 0.1mg/kg of Succinylcholine and 0.25mg/kg of  
 
Succinylcholine.  
 
3)  To ascertain if use of Succinylcholine, decreases Propofol consumption. 
 
4) To compare haemodynamics, in the three groups.  
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INTRODUCTION 
 
 
Ambulatory surgery is upcoming in all parts of the world as life becomes more fast pace and  
time is a limited commodity. In this setting general anaesthesia using the Laryngeal Mask  
Airway is widely used. Laryngeal Mask Airway insertion is accomplished using Propofol as it  
helps blunt the laryngeal reflexes well, when compared to other induction agents. (1) 
 
Often though it has been seen that Propofol as a sole agent is not sufficient to prevent  
patient movement, coughing and gagging.(2) Additional doses of Propofol are required to  
prevent these undesirable airway reflexes and multiple insertion attempts needed. These can be  
associated with adverse haemodynamic changes and airway trauma.  
 
 Numerous adjuvants have been studied and proven to aid insertion of the Laryngeal  
Mask Airway eg: Midazolam,(3) low dose Rocuronium,(4) Fentanyl(5) and Remifentanyl(2);  
thus reducing the Propofol requirements and avoiding the adverse haemodynamic changes that  
can occur with large doses of propofol. These also aid in smooth Laryngeal Mask Airway 
 insertion, avoiding unnecessary airway trauma. 
  
 Succinylcholine is a quick onset, short acting depolarizing muscle relaxant. It is a time  
tested drug, easily available and cost effective.  The use of Succinycholine to aid insertion of the  
Laryngeal Mask Airway is advantageous as it avoids depression of the respiratory centre and has  
no influence on consciousness, unlike opiods and benzodiazepines. Use of Succinylcholine to  
facilitate Laryngeal Mask Airway insertion has been studied in the past. Succinycholine has been  
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proven to facilitate Laryngeal Mask Airway insertion, with and without(6) an additional agent  
such as Fentanyl or Midazolam. Most of these studies used a single arbitrary dose and did not  
compare two doses to get an ideal dose. (7),(8), (3). This study compares two doses of  
Succinylcholine and placebo and aims to identify the ideal dose of Succinylcholine required to  
facilitate Laryngeal Mask Airway insertion.  
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REVIEW OF LITERATURE 
 
The review of literature is divided into the following topics: 
 
A) Ambulatory surgery-history, current standing, advantages, 
 
B) The Laryngeal Mask Airway- history, description, classification -types,  Laryngeal Mask 
Airway verses the Endo Tracheal Tube, Laryngeal Mask Airway in ambulatory surgery, 
systemic changes 
 
C) Use of the Laryngeal Mask Airway- size, checking the LMA and prepration of the mask, 
indications, contraindications, induction, insertion, cuff inflation and assessment of 
position and function, complications 
 
D) Succinylcholine- history, pharmacokinetics, pharmacodynamics, mechanism of action, 
Dibucaine number, clinical uses and side effects 
 
E) Studies on various adjutants to aid Laryngeal Mask Airway insertion 
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A) AMBULATORY SURGERY 
 
Ambulatory surgery or day care surgery is clinical admission for a surgical procedure, with  
discharge of the patient on the same working day. 
 
History 
 
The first ambulatory surgery centre was started in Arizona, USA in 1970, by two  
physicians who felt the need for timely, convenient and comfortable surgical services for  
patients. Ambulatory surgery existed in 1960s, but in conjunction with hospitals. In 1973  
the American Society of Anaesthesiologists released the “Guidelines for Ambulatory  
Surgical Facilities,” a list of nine criteria approved by the ASA House of Delegates. In  
the 1970‟s and 80‟s there was rapid growth and numerous centres opened up.  
 
 
Current standing 
 
 
Currently two thirds of surgeries performed are in the ambulatory setting.(9) In the year  
1998-1999, statistics showed that 65% of elective surgery was performed in the  
ambulatory setting in the United Kingdom, and 70% of the same in the United States of  
America.(10) In developing countries too ambulatory surgery is fast becoming the  
preferred procedure. In India with the ever expanding load of patients, low doctor to  
patient ratio and need for more beds; ambulatory surgery is fast becoming the preferred  
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choice. “The day care market in top 10 cities of India is expected to grow from `1,800 Cr  
in 2010 to `4,600 Cr in 2015 at a CAGR of 20 percent”, according to the CEO of Patni  
Health Care.  
 
The advantages 
 
 
 The concept of „Day Care‟ Surgery was welcomed by patients, nurses, surgeons and  
anaesthesiologists. 
 For the patient it meant lesser duration of hospital stay, early return to normal  
daily activities, less leave from work, and most importantly less costs incurred.  
For the nurses it meant dealing with less morbid patients and visualizing quick post 
 operative recovery. For the surgeon too quick recovery was satisfying and the fast pace,  
challenging. For the anaesthesiologist it meant modifying the techniques and drugs that  
were routinely used in the past, to ensure that same day discharge was a reality.  
Ambulatory surgery has become so specialized today that specialized ambulatory surgery  
teams have been proven to contribute to decreased surgery recovery room length of  
stay(11). 
Early recovery is aimed at by the entire team, the surgeons altering their technique  
and the anaesthesiologist altering theirs too accordingly. In this light the Laryngeal Mask  
Airway came to be one of the answers to what anaesthesiologists were looking for to  
enhance early recovery. Though the Laryngeal Mask Airway was first brought about with  
the difficult airway in mind, it‟s use as an alternative to the endotracheal tube in the  
ambulatory setting was a discovery that was welcomed. Numerous studies were done in  
the early nineties proving that the use of the Laryngeal Mask Airway enhanced early  
recovery (12)(13)(14)(15).   This study was done in the ambulatory surgery centre of  
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this hospital. It included general surgical procedures like Examination  
Under Anaesthesia and Lay Open Fistulae, haemorroidectomies, lipoma, breast lump 
 excisions, Orthopaedic procedures like implant exits and knee arthroscopies, Urological  
procedures like cystoscopies, circumcisions; and ENT procedures like tympanplasties. 
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B) THE LARYNGEAL MASK AIRWAY 
 
 
History  
 
First designed by Dr. A I I Brain, the Laryngeal Mask Airway was made to  
combat the difficult airway. The first skill taught to any inspiring anaesthesiologist is how  
to handle the airway. Upper airway obstruction is the most common complication of general  
anaesthesia and can be life threatening if not overcome(16). The art of holding the face mask  
using the head tilt, chin lift and jaw thrust is life saving in many situations. The Guedel‟s oral  
airway improves patency. These methods though can be associated with aspiration of gastric  
contents, and can be difficult in patients with beards, obesity, facial deformities, those who are  
edentulous etc. As these methods also required the anaesthesiologist‟s hands to be „tied‟,  
endotracheal tube insertion came as a breakthrough. It was first introduced in 1878(16). Yet this  
too has problems of its own. Muscle relaxation is needed, noxious airway reflexes can be  
stimulated and the incidence of sore throat and injury to the laryngeal apparatus is higher(17).  
Securing the endotracheal tube in the correct position in patients with difficult airways is not  
always easily accomplished.  
 
With all this in mind Archie Brain devised the Laryngeal Mask Airway; a mask that was  
smaller than the face mask and could slip into the mouth and be positioned comfortably over the  
laryngeal apparatus, providing a conduit for air, oxygen and anaesthetic gases to pass into the  
trachea and lungs(16). He made plaster casts of the cadaveric pharyngeal space to understand it‟s 
 anatomy. He realized the space was boat shaped and improvised with the Goldman dental mask,  
detaching the black rubber cuff and drawing it into the shape of an inflatable rubber boat. The  
proximal end was attached to a tube to complete what then became the Laryngeal Mask Airway.  
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THE GOLDMAN DENTAL MASK 
 
Archie Brain went through long hours of work trying to bring about an acceptable device.  
He was born in Japan, during the World War 2, when his father was the British consul in Kobe.  
Similar to how Thomas Alwa Edison described his invention, the invention of the Laryngeal  
Mask Airway was “1% inspiration in 1981 and 99% perspiration over the next ten plus  
years”(18). Contrasting Edison who had numerous co workers, Archie Brain singlehandedly  
worked in a small workshop, developed different prototypes and tested them on his patients. It 
 probably would be much harder today considering the strict and regulated research environment  
that currently exists (18). 
  
 The first prototype Laryngeal Mask Airway was used in 1981, in a forty year old male  
who underwent an elective inguinal hernia repair(19). Gradually the Dunlop Rubber Company  
made some latex and later on silicon masks. The first independent clinical trial was carried out in  
1987 in the Northwick Park Hospital and in a year‟s time the design was finalized and different  
sizes available(20).  
 
Description  
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The classic Laryngeal Mask Airway consists of three main parts 1) a shaft proximally  
 2) an elliptically shaped inflatable mask distally which lodges over the pharynx and the larynx  
and 3) a mask inflation line. The mask is an inflatable cuff and has a pilot balloon to ensure the  
same.  
 The shaft is slightly curved, so that it stays aligned with the axis of the airway,  
semirigid so that it does not bend on itself and semitransparent so that secretion or regurgitant  
material can be visualized immediately. There is a black line along the posterior border of the  
shaft that allows orientation of the position of the tube. The aperture at the distal end of the tube 
 that opens into the lumen of the mask is protected by two flexible vertical rubber bars, which 
 prevent the epiglottis from obstructing the airway. 
 
 
The inflatable mask is elliptical in shape. It has a broader, rounded proximal end and  
a narrower distal end. The  mask is semi rigid, concave, and is attached to a shield like backplate.  
The concave aspect of the mask is called the bowl. 
 
The mask inflation line attaches to the proximal part of the mask in the midline and  
has four parts, the inflation line, inflation balloon or pilot balloon, a metallic valve and a syringe  
port. The valve is made of polypropylene and it has a stainless steel spring(21). 
 
 On inflation the cuff conforms to the anatomy of the upper airway. The bowl of the  
cuff faces the space between the vocal cords. Thus it acts as a device to connect the artificial  
airway to the upper end of the respiratory tract in an end to end fashion. A face mask seals  
against the face and the endotracheal tube penetrates too deep into the respiratory tract. Dr Brain 
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 wrote in his diary in May 1981, "Better, use a loop fitting into the anatomical loop of space 
 surrounding the larynx, with a projection downwards into the oesophagus, which could be 
 hollow, to drain regurgitant fluid”(16) 
 
                 
THE CLASSIC LARYNGEAL MASK AIRWAY 
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THE LARYNGEAL MASK AIRWAY IN POSITION 
 
Types 
 
Various types of Laryngeal Mask Airways are available. The term Supraglottic Airway refers to  
a family of devices that enable ventilation and oxygenation without an passing through the vocal  
cords, such as the Laryngeal Mask Airway. They can be broadly classified based on the  
mechanism of laryngeal sealing or by the evolution of the device(22). 
 
CLASSIFICATION OF SUPRAGLOTTIC AIRWAYS BASED ON SEALING MECHANISMS 
 
  Perilaryngeal sealers: The LMA family, i-gel, air-Q Intubating Laryngeal Airway 
(airQ ILA) 
 
 Pharyngeal sealers: Combitube, the Streamlined Liner of the Pharynx Airway 
(SLIPA), the Laryngeal Tube 
 
 
 Both: The Cobra Perilaryngeal Airway (CobraPLA) 
 
CLASSIFICATION OF SUPRAGLOTTIC AIRWAYS BASED ON EVOLUTION 
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  First-generation devices: Simple airway tubes- 
The laryngeal mask airway [classic LMA (cLMA)], flexible LMA (fLMA), unique 
LMA (ULMA) and The Cobra Perilaryngeal Airway (CobraPLA) 
 
  Second-generation devices: With addition of Drainage tube- 
Proseal LMA (PLMA), i-gel, Laryngeal tube, LMA Supreme, Streamlined Liner of  
the Pharyngeal Airway (SLIPA) 
 
Laryngeal Mask Airway verses the endotracheal tube  
 
After so many years of use of both the Laryngeal Mask Airway and the endotracheal tube; the  
preference of each in different situations has now been comfortably delineated, though  
interchangeability depending on the user‟s comfort and experience does exist.  
 
In ambulatory surgery 
 
Early recovery and fewer side effects are the main aim of an anaesthesiologist during  
ambulatory surgery. When ambulatory surgery started gaining popularity the beneficial use of 
 the Laryngeal Mask Airway in this setting was identified. Studies were done to prove the same. 
 It was seen that the endotracheal tube was associated with a greater haemodynamic response to 
 insertion, skin incision and removal. The overall use of morphine was therefore more with the 
endo tracheal tube. There was less coughing with the Laryngeal Mask Airway(12). Considering 
that overall use of Morphine was less with the Laryngeal Mask Airway, one can deduce that 
awakening was better and post operative nausea and vomiting too were less.  
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A prospective, randomized multicentric study was done three years following the  
previous study comparing use of the endotracheal tube and Laryngeal Mask Airway in the  
ambulatory setting(15).  There were close to two hundred patients in each group. The duration of 
 stay in the post anaesthesia care unit and the time to ambulation was significantly shorter in the  
Laryngeal Mask Airway group. Intra operative Fentanyl used in the Laryngeal Mask Airway  
group was less, though it was not found to be statistically significant. There was no difference in 
 the incidence of post operative nausea and vomiting, or in the need for rescue antiemetics. The  
study however did show a significantly higher incidence of post operative sore throat in the  
endotracheal tube  group.  
 
Laryngeal Mask Airway tolerates lighter planes of anaesthesia 
 
 One of the major advantages of the Laryngeal Mask Airway that is particularly beneficial  
in the ambulatory setting is that it causes very little stimulation and it tolerates lighter levels of  
anaesthesia ( LMA User‟s Manual, Intavent International). This is beneficial as it provokes fewer 
 episodes of coughing, breathholding and laryngospasm during emergence, when compared to an  
airway like the endotracheal tube that requires deeper planes of anaesthesia. Lighter planes of  
anaesthesia also causes less cardiovascular depression and has shorter recovery times(23). 
 
Laryngeal Mask Airway is associated with a lower risk of airway complications 
 
 A systematic review of randomized prospective controlled trials was done in 2010 to  
compare the airway complications associated with the Laryngeal Mask Airway and the  
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endotracheal tube(24). 29 trials were included. It was found that there was a clinically and 
 statistically significant difference in the incidence of laryngospasm during emergence, coughing, 
 hoarseness of voice and sore throat; the endotracheal tube being associated with a higher  
incidence of these complications. There was no statistically significant difference in the  
incidence of nausea, vomiting, risk of regurgitation, or success of insertion on first attempt  
between the two groups. 
 
Systemic changes- cardiovascular, neurovascular, intraocular- a comparison  
 
Cardiovascular- Haemodynamic changes to insertion of the Laryngeal Mask Airway have  
been studied and often compared to the endotracheal tube. Mizrak et al looked at the heart  
rate, mean arterial blood pressure, P wave dispersion and QT dispersion in 75 patients(25).  
The comparisons were, made between insertions of the endotracheal tube, double lumen tube 
 and laryngeal mask airway. Recordings were made immediately before insertion and at 1, 3, 
 5, 10, 15, 20, 25 and 30 minutes after insertion. All the patients were induced with 
 Etomidate 0.3mg/kg and Fentanyl 1μgm/kg, and maintained with nitrous oxide, oxygen, 
 Sevoflurane and Rocuronium 0.5mg/kg. It was found that there was no change in the heart 
 rate, mean arterial blood pressure or P wave dispersion, during or after placement of the 
 Laryngeal Mask Airway. There was QT dispersion though after placement. The heart and 
 mean arterial blood pressure were significantly higher in the first minute, in the endotracheal 
 tube group, when compared to the Laryngeal mask airway group.  
 
Neurocirculatory- Heart rate, mean arterial blood pressure and muscle sympathetic nerve  
activity were compared between the Laryngeal Mask Airway and endotracheal tube(26).  
Muscle sympathetic nerve activity was checked using an electrode in the peroneal nerve. It 
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 was found that the endotracheal tube group had a 27% increase in heart rate and a 42%  
increase in mean blood pressure compared to 12% and 23% increase respectively in the  
laryngeal mask airway group. The muscle sympathetic nerve activity increased 600% in the 
 endotracheal tube group compared to 66% in the Laryngeal Mask Airway group. The time  
to return to baseline values of heart rate and mean arterial blood pressure were also higher in 
 the endotracheal tube group. The Laryngeal Mask Airway is thus useful in situations where  
heart rate and blood pressure should be stable. 
 
Intraocular- The ocular hypertensive response to manipulation of the airway can cause  
considerable rise in intraocular pressure. This has been shown to be significantly less with 
 insertion and removal of the Laryngeal Mask Airway when compared to the endotracheal 
 tube(27). 
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C) USE OF THE LARYNGEAL MASK AIRWAY 
 
 
Size 
 
  The appropriate sized Laryngeal Mask Airway is to be chosen. A size smaller and larger  
 
must always be handy. Laryngeal Mask Airways are available in eight sizes. The smallest 
 
 size can be used in neonates. The cuff is 15% larger as each size increases (21). The 
 
 following table describes the appropriate Laryngeal Mask Airway for the weight and the 
 
 amount of air that needs to be inflated in the cuff. This is for the classic LMA. This is to be  
 
used as a guide to selecting the appropriate size and clinical judgment must not be ignored  
 
taking patient anatomy also into consideration. When in doubt it is safer to use a larger rather  
 
than a smaller Laryngeal Mask Airway for the first attempt(28). 
 
 
 
Table 1 (21) 
Mask size Patient weight in kg Maximum volume of air 
inflated (ml) 
1 Neonates/infants <5 4 
1.5 Infants between 5-10 7 
2 Infants/children between 10-
20 
10 
2.5 Children between 20-30 14 
3 Children 30-50 20 
4 Adults 50-70 30 
5 Adults 70-100 40 
6 Adults >100 50 
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 Checking the Laryngeal Mask Airway and preparation of the mask 
 
Airway mishaps can be averted by a simple step such as checking the Laryngeal Mask Airway.  
Visual inspection- Discolouration of the shaft should be looked for, as fluid in the tube may be  
missed if the shaft has darkened. Cuts and tears should be checked for and the spiral wires should  
not be kinked. The cuff must not have any foreign particles lodged in it, as these can lead to  
obstruction. The bars at the mask aperture should be gently probed to ensure that they are not  
damaged and to there are no particulate matter between the two bars. The connector should be  
checked for cracks and should fit tightly into the shaft(28). 
 
Deflation/ Inflation- The cuff should be fully deflated by withdrawing air from it with a syringe  
so that the walls are flattened. The syringe should be removed and the cuff should stay flattened.  
If it reinflates it indicates a faulty valve or leaking cuff. The cuff should then be inflated with  
50% more air than the maximum recommended for that size and cuff should hold pressure for at  
least two minutes. If there is deflation, thinning of the wall or herniation at any point, the  
Laryngeal Mask Airway must be discarded. The pilot balloon should be elliptical in shape. If it  
appears wider than it should, or spherical, it indicates weakness and chances of rupture exist.  
This test is mandatory and major accidents can be averted, if this is diligently done prior to  
induction (28). 
 
Prepration of the mask  
 
 The cuff should be fully deflated. A cuff deflating tool may be used , which increases the  
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life span of the Laryngeal Mask Airway. It could otherwise be deflated by pressing the concave  
side of the cuff on a clean, hard and flat surface. After complete deflation the cuff should be  
wrinkle free. A lubricant should be applied on the posterior surface of the cuff. Care must be  
taken to avoid spillage to the anterior surface. A water soluble jelly should be used. Analgesic  
containing gels should be avoided as return of protective reflexes may be delayed, and some  
patients may develop an allergic reaction to these gels. A gel that contains silicone may cause the  
mask to soften and swell (29). 
 
Indications and Contraindication 
 
Prior to planning on the use of a Laryngeal Mask Airway, the contraindications must be  
carefully thought of, and the its use indicated. 
 
Indications 
 
1) Short surgical procedures, including head and neck procedures(30). It‟s use in  
 
adenotonsillectomy, adenoidectomy and tonsillectomy is still gray. A retrospective  
 
review of 1199 records (2002-2006), showed the incidence of Laryngeal Mask Airway  
 
failure to be 6.8%. Patients undergoing adenoidectomy has lesser failure rates than  
 
adenotonsillectomy or tonsillectomy. Airway obstruction following insertion and  
 
placement of the mouth gag was the most common reason for complications. The ability  
 
of the surgeon to work around the Laryngeal Mask Airway played a major role in  
 
preventing airway complications. Male sex, younger patients, patients with co  
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morbidities and controlled ventilation also had higher incidence of complications. This  
 
review concluded that use of the Laryngeal Mask Airway for paediatric  
 
adenotonsillectomy was associated with higher incidence of complications compared to  
 
the endotracheal tube(31). Yet, another contemporary review of published articles in  
 
Pubmed, Medline and conference proceedings, showed the Laryngeal Mask Airway to be  
 
safe and efficacious in otorhinolaryngology and many head and neck procedures,  
 
including adenotonsillectomies. The Laryngeal Mask Airway can be used in the supine,  
 
prone, lateral, oblique, Trendelenberg and lithotomy position(32). Recommended  
 
duration by the manufacturer is 2-3 hours(31). 
 
2) Cannot ventilate cannot intubate scenario, if the problem is supraglottic in nature. In  
 
1996, the American Society of Aaesthesiologists added it in the Difficult Airway  
 
Algorithm in five different places as a method to ventilate and also as a conduit for  
 
intubation(21).  
 
3) Cardiopulmonary resuscitation 
 
Contraindications (21) 
 
1) Patients with mouth opening less than 1.5cms 
 
2) Poor lung compliance 
 
3) Airway pressures of more than 20cms of water 
 
4) Patients who are at risk of aspiration of gastric contents (full stomach, hiatus hernia with  
 
significant gastro oesophageal reflux, intestinal obstruction, delayed gastric emptying,  
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poor history, opiate medication prior to fasting(33))(32). 
 
5) Morbidly obese patients(33) 
 
6) Glottic or subglottic surgery(32) 
 
 Anaesthetic induction 
 
  Sufficient depth of anaesthesia is needed for insertion of the Laryngeal Mask Airway; as much  
as for an oropharyngeal airway, but not as much as for endotracheal intubation. No response to a  
jaw thrust is a good indicator of adequate depth. To date Propofol is the best induction agent. It  
has the added advantage of blunting laryngeal reflexes.   
 
Insertion(33)(21) 
 
There are many methods of inserting the Laryngeal Mask Airway. The standard insertion  
 method is what was first described. Any method is acceptable as long as the Laryngeal Mask  
Airway is lodged correctly and ventilation is adequate. 
 
Standard Insertion Method (pictures attached) 
 
Gloves must be worn. 
1) The plane of anaesthesia should be deep enough. Absence of response to a jaw thrust  
 
is method of checking adequacy of depth. 
 
2) The head should be extended and the neck flexed as for laryngoscopy and intubation. 
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3)  This can be done with the left hand, if insertion is being done with the right hand. 
 
 
4) The mask is held like a pen, with index finger lodged between the junction of the cuff  
and shaft, anteriorly.  The mouth is opened and the tip is pressed against the hard palate  
and lies against the palate as it is slid into the pharynx. The index finger is slid along with 
 the Laryngeal Mask Airway, into the mouth, maintaining backward pressure against the  
palate. 
 
5) As it is pushed further downwards, backward pressure is maintained against the  
 
posterior pharyngeal wall to avoid collision with the epiglottis. During this time the  
 
ventral surface of the entire index finger should lie against the shaft of the Laryngeal 
 
 Mask Airway.  
 
6) Once resistance is felt it means the airway is in place. By then the entire length of the  
 
index finger should be in the mouth. The remaining fingers should be outside the 
 
 mouth. As the index finger is being withdrawn, the other hand supports the shaft of  
 
the airway preventing it from coming out as the index finger is being withdrawn.  
 
7) The black line on the shaft should face the upper lip.  
 
8) The cuff should now be inflated with just enough air to seal. Cuff pressure must not  
 
exceed 60 cms of water. During inflation the shaft must not be held. The Laryngeal  
 
Mask Airway will rise slightly. This allows it to settle in a correct position. After this  
 
The gas supply can be connected to the airway. Care must be taken not to over inflate  
 
the cuff.  
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9) While connecting to the gas supply the shaft must be firmly held to prevent  
 
dislodgement. On ventilation of the lungs, adequate chest rise is looked for. A bite  
 
block, made of rolled gauze should be placed by the side of the shaft. The Laryngeal  
 
Mask Airway is then secured well, ensuring rotation and cranial movement is  
 
prevented. 
 
STEP 1 
 
 
STEP 2 
31 
 
 
STEP 3 
 
 
STEP 4 
 
 
Thumb insertion method (33) 
 
Here the Laryngeal Mask Airway is inserted with the anaesthesiologist facing the  
patient. It is useful in situations where access to the head end of the patient is  
difficult, for example during cardio pulmonary resuscitation. The thumb is placed  
between the proximal end of the cuff and the shaft, just how the index finger was  
placed in the classic method. The tip of the cuff is placed against the front teeth and  
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the cuff slid into the mouth against the palate using the thumb just as the in the classic  
method. As the cuff goes deeper into the mouth, the other four fingers are placed over  
the face and also help in extension. Flexion of the neck is provided by the pillow  
under the head. Once the thumb is pushed in maximally, the airway should be in  
place. As the thumb is taken out, the other hand holds the Laryngel Mask Airway in  
place.  
 
 
 
STEP 1    STEP 2 
 
 
 
STEP 4      STEP 5 
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180- degree technique(29) 
 
 
Commonly used in paediatrics, here the Laryngeal Mask Airway is inserted with the  
aperture facing cephalad. It is rotated 180 degrees once it reaches the hypopharynx. A  
discrete give may be felt. It has been believed that this method can cause dislocation  
of the aretynoids.   
 
Partial inflation technique (28) 
 
In this technique the cuff is partially or fully inflated. It is useful for beginners,  
though malposition is common. Partial inflation may be associated with less sore  
throat.   
 
Trouble shooting (28) 
 
If initial insertion is not satisfactory there are many maneuvers that can help. 
 
- Inserting the airway from the side of the mouth 
- Pulling the tongue forward 
- Jaw thrust 
- Repositioning the head 
- Applying continuous positive airway pressure (CPAP) 
- Minimal lateral rotation 
- Partial inflation of the cuff 
- Inserting  finger behind the mask, as a guide 
- Using a laryngoscope 
- Using a stylet or forceps 
34 
 
 
Position of a properly inserted mask is as follows. The mask rests on the floor of the  
hypopharynx. The sides of the mask face the pyriform fossa. The upper border of the cuff is  
behind the base of the tongue.  The tip of the epiglottis may be within the bowl of the mask or  
under the proximal part of the cuff. Even though position may not be perfect, satisfactory   
function can be achieved. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
Cuff inflation and assessment of position and function 
 
The cuff must be inflated with air, the maximum amount not exceeding what is specified  
for a particular size. It should be inflated over 3-5 seconds. The shaft must not be held during  
inflation, a slight movement upwards occurs, and a small bulge becomes visible in the neck. The  
cuff must not be visible in the mouth. The maximum volume of air for a particular cuff is rarely  
needed. The cuff pressure should be approximately 60 cms of water. The cuff pressure monitor is  
the best means of assessing this. Feeling the tension in the pilot balloon is a subjective way of  
assessing the same. A spherically shaped pilot balloon would mean too much gas in the cuff. If  
greater than recommended volumes are apparently needed, it is often a smaller size cuff that has  
been used. In such a situation it is better to use a larger sized Laryngeal Mask Airway, rather  
than inflate larger volumes of air, as this tends to worsen the seal of the cuff against the larynx.  
The ideal way of filling the cuff would be to inflate it with half the maximum volume of air that  
is required, determine the oropharyngeal leak and inflate more air if needed. Adequate chest rise  
to squeezing the bag, normal breath sounds,  and a good end tidal CO2 trace are reliable signs of  
proper position and function. Other elaborate ways of checking position are by passing  
fiberscope or rigid endoscope through the Laryngeal Mask Airway, this also helps rule out  
airway obstruction (28). 
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 If the airway is obstructed, common causes are  
- Incorrect mask position 
- Downfolded epiglottis 
- A closed glottis sphincter 
- An overinflated cuff 
Often removing and reinserting the mask solves the problem.  
 If spontaneous ventilation is being used, the leak pressure should be more than 10 cms of  
water and if positive pressure ventilation is being used, the leak pressure should be more than 20  
cms of water. 
 
Methods of determining airway sealing pressure 
1) Bourdon  pressure gauge 
2) Listen for a leak with a stethoscope placed lateral to the thyroid cartilage 
3) Listen over the mouth for a noise when the bag is squeezed 
4) A sample line in the oral cavity may detect CO2 if a leak is present 
5) Determine a steady airway pressure after closing the adjustable pressure valve in the  
circle system. 
 
 
Complications (32) 
 
1) Gastrooesophageal reflux and aspiration 
 
2) Laryngospasm, coughing, gagging, retching, bronchospasm 
 
 
3) Sore throat (0-70%, approximately 10%), hoarseness (4-47%), dysphagia (4-24%) 
 
4) There have been reports of nerve injury. Pressure neuropraxia is the most common 
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cause. 26 cases were reported as of Sept 2006. Nerves injured were hypoglossal,  
 
recurrent laryngeal and lingual nerves. Onset of symptoms was from emergence to 48  
 
hours after surgery. Spontaneous recovery occurred in all cases except one. Recovery  
 
occurred in 1hour to 18 months. 
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D) SUCCINYLCHOLINE 
 
Muscle relaxants interrupt transmission of the nerve impulse at the neuromuscular junction. 
 
 They are broadly divided into depolarizing neuromuscular blocking drugs that mimic the  
 
action of acetylcholine, and nondepolarizing neuromuscular blocking drugs that interfere  
 
with the action of acetylcholine. Succinlycholine is a depolarizing neuromuscular blocking  
 
drug(34). 
 
 
History of muscle relaxants (35)(34) 
 
Close to 500 years ago explorers who returned from South America first spoke of a  
poisoned arrow that was used in hunting and in war. This was curare. It fascinated man to further  
study this poison that killed immediately. The first mention of poisoned arrows though dates way  
back further in time and was mentioned by Homer (Odyssey, 1, 260) and Virgil (Adeneid, 9, 
772).  
 
One of the first persons to report on this intriguing drug was Sir Walter Raleigh (1552- 
1618). His first lieutenant Laurence Keymis, coined it „ourari‟, in an attempt to make it sound  
like the Macusi Indian pronunciation of the drug. The drug was brought to Europe and extensive  
research was done on it in the 18
th
 century. Yet for close to 175 years there was no clinical use of  
the drug. There was a report in 1912, of the drug facilitating closure of the abdomen, but this was  
ignored. 
 
 In 1935 the active compound from the plant Chondodendron was isolated and called D-  
tubocurarine. Its main use was to control muscle spasms in patients with tetanus. Richard Gill  
had an interest in primitive medicine and set up fort in Ecuadore. He unfortunately developed a  
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painful, spastic muscle disorder. This though is what led him to acquire 11kgs of a dark tar like  
paste- crude curare from the Indians, who were willing to share their secret material with him as  
he had won their rust. Squibb and Sons, Inc prepared a sterile injectable solution of D-  
tubocurarine and called it Intocostrin. This was first used by Bennett, a psychiatrist for electro  
convulsive therapy in 1940. Squibb and Sons along with an anaesthesiologist, Wright were  
convinced that “the true home for curare was with the anaesthesiologist” They were right and it  
was first used by Harold R. Griffith in 1940 during general anaesthesia. A breakthrough was  
made and many began to use the muscle relaxant during general anaesthesia. Of course the  
problems of inadequate reversal gradually came to light and the concept of using a peripheral  
nerve stimulator came about in 1952.  
 
Numerous other muscle relaxants were introduced and the methonium compounds, from  
plant alkaloids were one among them. The parasympathomimetic effects of Succinylcholine  
were already being studied in 1906, this masked the neuromuscular blocking properties of the  
drug. Succinylcholine‟s neuromuscular blocking effects were  identified in 1949, and the drug  
was introduced by Thesleff, Foldes an d colleagues in 1952. Daniel Bovet won the Noble Prize  
in 1957, for the discovery of the same. This rapid onset, ultrashort acting drug was a seen as a  
boon to anaesthesiologists, and changed anaesthetic practice drastically as rapid endotracheal  
intubation became possible. D-tubocurarine and Succinylcholine were the most commonly used  
muscle relaxants in the 1950s to 60s. Steroid based neuromuscular blocking agents like  
Pancuronium, Vecuronium and Rocuronium were identified in the 1960s to 1990s. Their  
improved safety profile, compared to older drugs like curare and gallamine was well welcomed.  
Foldes and colleagues stated that “the use of muscle relaxants not only revolutionized the  
practice of anaesthesia but also started the modern era of surgery and made possible the  
explosive development of cardiothoracic, neurologic, and organ transplant surgery.” 
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PHARMACOLOGY OF SUCCINYLCHOLINE 
 
Structure- activity relationships 
 
It is a quaternary ammonium compound and is structurally similar to acetylcholine. The  
positive charges get attracted to the alpha subunit of the muscle and neuronal type nicotinic  
acetylcholine receptors at the neuromuscular junction. The neuronal type nicotinic receptors are  
also present in autonomic ganglia, along with at least five different kinds of muscarinic  
receptors. Neuronal nicotinic and muscarinic receptors are also present prejunctionally at the  
neuromuscular junction.  
 
Succinylcholine consists of two molecules of acetylcholine attached together through the  
acetate methyl groups. It is a long, thin and flexible molecule. It stimulates the cholinergic  
receptors and opens the ion channel in it.  
 
 
 
 
Pharmacokinetics and Pharmacodynamics 
 
Succinylcholine is still the only muscle relaxant which has a rapid onset and ultra short  
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duration of action.  Its ED95 is 0.51- 0.63 mg/kg, that is, the dose required for desired effect in  
95% of the population. 1mg/kg of Succinylcholine gives adequate muscle relaxation for  
intubation within 60 seconds. Considering that different patients respond differently, a dose of 1- 
1.5mg/kg is appropriate for complete neuromuscular blockade. Recovery to 90% of muscle  
strength occurs in 9 to 13 minutes in those with genotypically normal butyrylcholinesterase (also  
knowm as plasmacholinesterase or pseudocholinesterase).  
   
Succinylcholine gets hydrolysed rapidly by butyrylcholinesterase, which is present in the  
plasma, to succinylmonocholine and choline. Butyrylcholinesterase has enormous capacity to  
hydrolyse Succinylcholine and hydrolyses it before it reaches and after it diffuses away from the  
neuromuscular junction. Because of this only 10% of the administered drug actually reaches the  
neuromuscular junction. Butyrylcholinesterase thus affects the onset and duration of action of  
Succinylcholine. Succinylmonocholine is a weaker neuromuscular blocking agent and gradually  
gets metabolized into succinic acid and choline. The elimination half life of Succinylcholine is  
around 47 seconds.  
 
Mechanism of action(35)(34) 
 
Structure of the nicotinic acetylcholine receptors and the adjacent Na channels 
It is a pentameric complex, which consists of two α subunits and one each of β, δ and ε  
subunits. These subunits form a transmembrane channel. Acetylcholine, as well as muscle  
relaxants bind to the α subunit. Mature receptors have a short burst duration and higher  
conductance for Na, K and Ca ions. Fetal receptors on the other hand differ in structure with the  
ε subunit being replaced by a γ subunit; functionally they have a prolonged open channel time  
and are a low conductance channel. The receptor just described is present at the end plate. 
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  Adjacent to the end plate, perijunctionally are the sodium ion channels. These channels  
open in response to a transmembrane change in voltage. These too form a transmembrane  
channel. Structurally they have two gates, the upper one being voltage gated and the lower one  
being time gated. Depending on whether these gates are open or closed, the sodium channel exits  
in three states. 1) The resting state where the voltage dependent gate is closed and time  
dependent gate is open, 2) the active state where both channels are open and the flow of Na ions  
occurs and 3) the inactive state where the voltage dependent gate is open and the time dependent  
gate is closed.  
 
 When acetylcholine binds to the receptor, the membrane depolarizes. The adjacent  
sodium channels sense the voltage change and the voltage dependant gate opens. Since the time  
dependant gate is already open, sodium flows into the cell. After some time the time dependant  
gate closes. The voltage gate stays open as long as it senses a change in voltage around it  
(depolarization). It does not close until the depolarization disappears. The time gate on the other  
hand cannot open again until the voltage gate closes. This is the basis of the mechanism of action  
of Succinylcholine.   
 
 Succinylcholine is a partial agonist and mimics the action of acetycholine at the nicotinic  
acetycholine receptors. It attaches to one or both of the alpha subunits and causes depolarization  
of the postjunctional membrane. Normally when acetylcholine attaches to the receptor it gets  
hydrolysed fast because acetylcholinesterase is present in the neuromuscular junction itself.  
Succinylcholine gets hydrolysed much slower leading to a sustained depolarization (opening) of  
the ion channel, with the voltage gate being open and the time gate being close, ie) the sodium  
channels stay in the inactive state, till the relaxant is removed. Thus the membrane cannot  
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respond to subsequent release of acetylcholine and neuromuscular blockade develops. This  
depolarizing block is called Phase I block. This sustained opening of the ion channel leads to  
leakage of potassium ions out of the cell and increase serum levels by 0.5mEq/L.  
  
A single large dose of Succinylcholine (>2mg/kg), repeated doses or an infusion can lead  
to what is known as the Phase II block. The junction gets depolarized initially, the membrane  
potential gradually returns to normal, even though the drug is still attached, but neuromuscular  
transmission does not occur. A conformational change occurs in the receptor, not allowing it to  
open. Many reasons for this exist. A) Repeated channel opening causes a continuous efflux of  
potassium and influx of sodium, leading to abnormal electrolyte balance and thus abnormal  
response of the junctional membrane. B) Calcium that enters the cell causes a disruption of the  
receptors. C) Desensitization- refers to receptors that have bound to agonists but do not open.  
The exact mechanisms are not known.  Normally binding of Succinylcholine leads to only a  
transient state of desensitization. But when large doses, repeated doses or an infusion is given the  
receptor gets trapped in a desensitized state.  
   
Dibucaine number and butyrylcholinesterase activity 
 
Butyrylcholinesterase is produced in the liver. The activity of the enzyme is depicted by  
the number of substrate molecules (μmol) hydrolysed per unit of time. This can be expressed as  
IU (International Units). Since the normal enzyme is highly active, significant decreases in its  
activity result in only a modest increase in duration of action of Succinylcholine, which is  
clinically not very significant. Factors that lower butyrylcholinesterase activity are liver disease,  
old age, malnutrition, burns, pregnancy, malignancies and drugs like oral contraceptive pills,  
MAO inhibitors, cytotoxic drugs, echothiophate, anticholinesterases, metoclopramide, esmolol  
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and bambuterol, the prodrug of terbutaline.    
 
What was found to be clinically significant though was if there was an abnormal genetic  
variant of butyrylcholinesterase. Dibucaine is a local anaesthetic that inhibits  
butyrylcholinesterase. It was found that it inhibits the normal enzyme to much larger extent than  
the abnormal enzyme. Thus the concept of Dibucaine number came about, as a test to determine  
the genetic makeup of an individual with respect to butyrylcholinesterase. Dibucaine number  
indicates the percentage of enzyme inhibited. It is a qualitative test and not a quantitative test.  
Dibucaine inhibits the normal enzyme by around 80% and the abnormal enzyme by around 20%.  
Dibucaine resistant varieties are of most significance. The following table shows us the  
relationship between Dibucaine number and the duration of Succinylcholine neuromuscular  
blockade.  
       
Genetic type of 
butyrylcholinesterase 
Incidence Dibucaine number Response to 
Succinylcholine 
Typical- homozygous Normal 70-80% Normal 
Atypical- 
heterozygous 
1/480 50-60% Lengthened by 50-
100% 
Atypical- homozygous 1/3200 20-30% Prolonged to 4-8 
hours 
 
  
Since the Dibucaine number is not a quantitative test, it does not measure the  
concentration butyrylcholinesterase, nor does it estimate the efficiency of the enzyme to  
hydrolyse Succinylcholine. These can be acquired by measuring the butyrylcholinesterase  
activity.  
 
The molecular biology of butyrylcholinesrase has been extensively researched and well  
understood. Most often genetic variants are due to single amino acid substitution or sequencing  
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errors, at or near the active site of the enzyme.  
 
Clinical uses 
 
Despite Succinylcholine having been discovered way before other currently being used  
non depolarizing agents, its use in clinical practice has still not been displaced. This is due to its  
rapid onset, profound depth and short duration of action. It is the agent of choice in rapid  
sequence intubation and proves beneficial above all neuromuscular blocking agents in an  
anticipated difficult airway (35). Conventionally 1mg/kg of Succinylcholine is used for  
intubation, in 60 seconds. A prospective, randomized double blinded study done on 200 patients,  
and published in 2003, relooked into the intubating dose of succinylcholine and concluded that  
intubation conditions similar to 1mg/kg Succinylcholine were achieved within 60 seconds with  
0.3 and 0.5mg/kg of Succinylcholine. Quicker return of spontaneous respiration and airway  
reflexes was the stated advantage (36). 
 
Side effects(35) 
1) Cardiovascular 
2) Hyperkalemia 
3) Increased intraocular pressure 
4) Increased intragastric pressure 
5) Increased intracranial pressure 
6) Myalgias 
7) Masseter spasm 
 
1) Cardiovascular 
 
The cardiovascular effects of Succinylcholine are because it stimulates all the  
cholinergic receptors in the body, which include the nicotinic receptors in the sympathetic and  
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parasympathetic ganglia, as well as the muscarinic receptors in the sino atrial node of the heart.  
At low doses Succinylcholine induces a negative ionotropic and chronotropic effect, but at  
higher doses it induces tachycardia (37). The common arrhythmias it induces are sinus  
bradycardia, junctional rhythms and ventricular dysrhythmias.  
 
Sinus Bradycardia- This is due to stimulation of cardiac muscarinic receptors in the  
sinus node. It is more predominant in children due to their higher vagal tone. Prior administration  
of Atropine can blunt this bradycardia. In adults it commonly occurs approximately five minutes  
after a second dose of Succinylcholine. Other than stimulation of sinus node muscarinic  
receptors, direct myocardial effects and ganglionic stimulation may also contribute to the  
bradycardia, as drugs like thiopental, atropine, ganglion blocking drugs and non depolarizing  
agents too help prevent the bradycardia. Also since bradycardia is more after the second dose,  
the breakdown products of Succinylcholine, Succinylmonocholine and choline may be  
implicated in sensitizing the heart to a second dose.  
 
Nodal/ junctional rhythms- These are also common after Succinylcholine, particularly the  
second dose. It may be due to excessive stimulation of the nodal muscarinic receptors causing  
their suppression. This leads to firing from the AV node.  
 
Ventricular dysrhythmias- These can certainly be alarming. There is an increased release of  
catecholamines with administration of Succinylcholine and also a decreased threshold of the  
ventricles to catecholeamine induced arrhythmias. The hyperkalemia induced by  
Succimylcholine further aggrevates arrythmogenicity. Other autonomic stimuli induced by  
endotracheal intubation, hypercarbia, hypoxia and the stress of surgery itself can add on to  
arrythmogenicity. There can be ventricular escape beats due to severe suppression of the sinus  
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and AV node.  
 
2) Hyperkalemia  
 
Normally there can be a rise in serum potassium values by 0.5mEq/l. This occurs due to  
depolarization of the muscle membrane by Succinylcholine and subsequent efflux of potassium  
due to the influx of sodium. Patients with renal failure are no more susceptible to this release in  
potassium, but if potassium levels are already high, Succinylcholine is better avoided to prevent  
further rise in potassium.  
 
 Patients with severe metabolic acidosis and hypovolemia can have an exaggerated  
hyperkalemic respose to Succinylcholine. They have higher resting potassium too. This  
potassium release is apparently from the gastrointestinal cells rather than muscle cells. Some  
amount of correction of the acidosis with sodium bicarbonate and hyperventilation can be  
instituted prior to administration of Succinylcholine. In case hyperkalemia does occur it should  
immediately be corrected with 1-2gms of Calcium chloride intra venously to stabilize the  
membranes, hyperventilation, 1mg/kg sodium bicarbonate, 10U regular insulin in 50ml of 50%  
dextrose in adults and 0.15U/kg of regular insulin in 1ml/kg of 50% dextrose. It has been found  
that in patients with severe abdominal infections particularly those lasting for more than a week  
have high chances of hyperkalemia with Succinylcholine, potassium values rising by around  
3.1mEq/L. This can pose a serious risk of cardiac arrest in these patients.  
 
 After massive trauma a patient is susceptible to hyperkalemia even 60 days following the  
trauma or until the damaged muscles have healed completely. Potassium can rise by up to  
3.6mEq/L, which can cause cardiac arrest. It was found that prior administration of d-  
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tubocurarine can negate this.    
 
 Hyperkalemia following administration of Succinylcholine to those who have developed  
extrajunctional receptors can also be life threatening. Examples are post burns, post  
cerebrovascular accident leading to hemiplegia or paraplegia etc, Guillain- Barre syndrome,  
muscular dystrophies etc. This occurs because these extrajunctional receptors have increased  
permeability to potassium. 
 
3) Increased intra ocular pressure  
 
Succinycholine increases the intraocular pressure. This occurs within 1 minute of giving  
the drug, it peaks in 2-4 minutes and subsides by 6 minutes. The mechanism is probably due to  
contraction of tonic myofibrils. Nifedipine was found to decrease this increase in pressure and  
therefore a possible vascular mechanism like transient dilatation of choroidal vessels was  
postulated. The exact mechanism is still not clear. Though Succinylcholine causes this rise in  
intraocular pressure, it still can be in ophthalmic surgery, except when there is open injury to the  
globe. Varying studies are available regarding precurarization with a small dose of non  
depolarizing agent to decrease this raise in intraocular pressure. Other stimuli like endotracheal  
intubation itself or bucking on the tube too cause a raise in intra ocular pressure so what is more  
important is a smooth induction and sufficient plane of anaesthesia intraop. Now that agents such  
as Rocuronium are available, Succinylcholine may be replaced in this setting.  
 
4) Increased intragastric pressure 
 
A raise in intragastric pressure occurs with Succinylcholine, which is quite variable. It is  
probably due to fasciculations of the abdominal wall muscles and varies with the intensity of the  
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fasciculations. Prior administration of a non depolarizing agent prevents the fasciculations and  
thus the raise in intragastric pressure too. The pressure can rise up to 120cms of water. The  
cholinergic effects of Succinylcholine itself can add to the rise in intragastric pressure.  
 
Increased intragastric pressure would be significant if it causes incompetence of the lower  
gastrooesophageal sphincter. This requires a pressure of more than 28 cms of water. However in  
conditions such as pregnancy, gross ascitis, intestinal obstruction and hiatus hernia, the normal  
oblique angle of entry of the oesophagus to the stomach is altered. In these conditions an  
intragastric pressure of even less than 15 cms of water can cause incompetence. Therefore  
special precaution needs to be taken in these situations when Succinylcholine is being given,  
such as a defasciculating dose of non depolarizing agent.  
 
 Infants and children do not have much of a raise in intragastric pressure, probably  
because they do not experience as much fasciculations.   
 
5) Increased intracranial pressure 
 
 
Succinylcholine causes a transient raise in intracranial pressure. The exact mechanism  
is not known. It can be prevented with mild hyperventilation or a small dose of non depolarizing  
agent.  
 
6) Myalgia  
 
Incidence of myalgia due to Succinylcholine varies from 0.2- 89%. It has been found to  
occur more in women, and more often after minor surgery such as those done in the ambulatory  
setting(38). It is more in ambulatory rather than bed ridden patients. The myalgia is probably due  
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to the damage produced in the muscles due to unsynchronized contraction of muscles, during the  
fasciculations and prior to the paralysis. It was found that serum creatine kinase increased and  
myoglobinemia occurred after administration of Succinylcholine. Numerus reasons for post  
operative myalgia have been postulated, such as type and location of surgery, patient position  
during surgery, intubation trauma, post operative ambulation and post operative requirement of  
analgesics; and it is now thought to be multi factorial, succinylcholine being only one of the  
reasons(38). Though Naguib et al(39) found that pretreatment with lysine acetyl salicylate  
decreased post operative myalgia, suggesting that there may an inflammatory component to the  
myalgia more recent studies by Schreiber at al disprove this in two of his studies (40)(41), stating  
that pre treatment with paracoxib and dexamethasone do not decrease myalgia. Myalgia was  
found to be less in those who are physically fit(42). Numerus agents have been studied and are  
still being studied to prevent Succinylcholine induced fasciulations and  myalgia. It has been  
found that prevention of fasciculations does not necessarily prevent post operative myalgia.  
Lately it has also been found that post operative myalgia occurs after ambulatory surgery even in  
the absence of Succinylcholine. Thus other factors may contribute to myalgia. A study done by  
Joshi et al found that pretreatment with Rocuronium and d Tubocurarine decreased  
fasciculations, better than Cisatracurium, but incidence of post operative myalgia was not  
affected by pre treatment in the ambulatory setting(43). Menke at al also found that pre treatment  
with Rocuronium decreased fasciculations but did not decrease incidence of post operative  
myalgia, and was asscociated with more muscle weakness prior to induction(44). Other drugs  
found to decrease Succinylcholine induced fasciculations are Remifentanyl 1.5μgm/kg(45),  
though it did not decrease myalgia, Lidocaine 1.5mg/kg decreased myagia at 48 hours better than  
Rocuronium(46), Magnesium 40mg/kg decreases fasciculations and myalgia(47), Propofol  
3.5mg/kg decreases fasciculations and myalgia(48), and more recently the role of gabapentine is  
being studied in decreasing fasciculations and myalgia(49).  
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 Most data suggest that onset of myalgia is within the first 24 hours in 60 to 90% of  
patients(38). 
 
7) Masseter spasm(35) 
 
 
Increased tone of the masseter muscle can occur with Succinylcholine. This is most  
probably due to an exaggerated contractile response at the neuromuscular junction. It may be a  
sign of malignant hyperthermia, but isolated incidences of masseter spasm with Succinylcholine  
does not negate the use of “non triggering agents” . 
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E) STUDIES ON ADJUVANTS TO AID LARYNGEAL MASK AIRWAY INSERTION 
 
 
Numerous adjuvants have been tried to aid insertion of the Laryngeal Mask Airway.  
 
Studies continue to be done on the same. It has been found that the Laryngeal Mask Airway  
 
is easier to insert and has a quicker learning curve(50),(51),(52). Despite the ease in insertion  
 
it can still be associated with patient movement, coughing, gagging and other adverse patient  
 
responses. Hence; the need for an adjuvant. The following is a review of the various  
 
adjuvants that have been and continue to be studied, in chronological order. 
 
 
From when the use of the Laryngeal Mask Airway became popular, the search for an  
 
ideal adjuvant has been rampant. Beginning with the days of Etomidate and Thiopentone,  
 
where insertion was not smooth(6), Succinylcholine was studied to facilitate insertion of the  
 
Laryngeal Mask Airway. Yoshino et al found that 0.5mg/kg of Succinylcholine was required  
 
to blunt adverse airway reflexes associated with Laryngeal Mask Airway insertion. The  
 
induction agent he used was Thiopentone. Unfortunately this dose was also coupled with  
 
more myalgia and a longer duration of apnoea(6).  
 
 
Ho and Chui compared 0.1mg/kg Succinylcholine and placebo, with 2.5mg/kg of  
 
Propofol and found it to be better, with lesser insertion attempts and smoother insertion.  
 
Propofol requirement was less, thus there was less hypotension. The duration of apnoea was  
 
not found to be different. Myalgia though was more(7). 
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Once Propofol was discovered it was thought that the solution to problem was found, yet  
 
using Propofol alone was not sufficient. Nakazawa et al compared placebo, Midazolam and  
 
Fentanyl, in the attempt of trying to avoid a muscle relaxant. They found that the insertion  
 
conditions were significantly better in the Midazolam and Fentanyl group compared to the  
 
placebo group. The Fentanyl had more hypotension and hence concluded that Midazolam  
 
was better(53). Considering the use of the Laryngeal Mask Airway in the ambulatory setting,  
 
Midazolam would cause more clouding of consciousness when compared to an agent like  
 
Succinylcholine.  
 
 
Cheam and Chui found that Fentanyl 1μg/kg and Mivacurium 0.04mg/kg were equally  
 
effective in facilitating Laryngeal Mask Airway insertion with Propofol 2mg/kg as the  
 
induction agent. The duration of apnoea was more, but with little clinical significance(54). 
 
 
Alfentanyl 5μ/kg was compared with 10μ/kg and found to be better, as 10μ/kg was  
associated with more hypotension and longer duration of apnoea(55). 
 
Wafaa et al compared Midazolam 0.04mg/kg and 0.1mg/kg of Succinylcholine and  
 
concluded that Midazolam was superior with better insertion conditions, less change in  
 
haemodynamics, shorter duration of apnoea and less fasciculations and myalgia(3).  
 
 
Once Rocuronium came to the scene, different doses were tried to aid Laryngeal Mask  
 
Airway insertion. 100, 150 and 300μ/kg were compared and it was found that the optimal  
 
dose was 100μ/kg. These doses of Rocuronium need to be given before induction, thus the  
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chances of unpleasant effects of neuromuscular block are present(4).   
 
 
Lee et al concluded that 0.25μ/kg of Remifentanyl provided excellent insertion conditions  
avoiding the hypotension that was present with 0.5μ/kg of the same(2).  
 
Oral clonidine as premedication was found to decrease the Propofol required to insert the  
Laryngeal Mask Airway. But as with Midazolam or other opioids, it‟s sedative effects may not  
be acceptable in the day care set up(56). 
 
Ganatra et al compared Sevoflurane induction and Propofol induction after Fentanyl and  
 
also looked at costs and found that though Propofol induction was faster, insertion conditions  
 
were similar in the two groups. Haemodynamic stability was with Sevoflurane but costs were  
 
more(57). 
 
 
Hui et al compared Alfentanyl 10μ/kg and Fentanyl 1μ/kg and found that insertion  
 
conditions were better with Alfentanyl but duration of apnoea was significantly longer(58).  
 
Ang et al had also found the duration of apnoea with 10μ/kg of Alfentanyl to be signifantly  
 
long (55). 
 
 
In an attempt to prevent apnoea and airway obstruction in children, particularly in those  
 
with a difficult airway, Jae- Hyon Bahk et al compared different doses of  Ketamine and  
 
Lignocaine spray in the oropharynx with different doses of  Propofol and looked not just at  
 
insertion conditions, but also apnoea, airway obstruction and secretions.  They found that 3-  
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3.5mg/kg of Ketamine with Lignocaine spray provided satisfactory conditions. Most patients  
 
in the Propofol group experienced either apnoea or airway obstruction. Thus they concluded  
 
that in the difficult airway situation Ketamine and Lignocaine would be a safe option(59).  
 
 
Liou et al looked at 1mg/kg of Succinylcholine with Etomidate as the induction agent  
 
comparing it with 2μ/kg of Fentanyl and found that Succinylcholine had a higher success rate  
 
of insertion, better jaw relaxation and shortened time to insertion(8). 
 
 
Goh et al again looked into Ketamine to maintain haemodynamics and prevent apnoea.  
 
They found that 0.5 mg/kg of Ketamine with Propofol as the induction agent provided  
 
insertion conditions similar to the Fentanyl 1μ/kg group and better than the placebo group,  
 
maintaining haemodynamics and less prolonged apnoea(60).  
 
 
Chari et al compared Butorphanol and Thiopentone with Fentanyl and Thiopentone and  
 
found that the Butorpanol group had better insertion conditions compared to the Fentanyl  
 
group(61). 
 
 
Etomidate being cardio stable was studied again. Its main disadvantage is that it does not  
 
blunt laryngeal reflexes like Propofol does. A study by Uzun et al though found that addition  
 
of Remifentanyl to Etomidate did not improve insertion conditions(62). 
 
 
As studies continue to be done, the α 2 agonist Dexmeditomidine was studied by  
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Uzumcugil. One group received 1μ/kg Fentanyl with Propofol and the other 1μ/kg  
 
Dexmeditomodine with Propofol. They found that insertion conditions were similar to  
 
Fentanyl and  respiratory function and haemodynamics were preserved better. Time to  
 
emergence though was more prolonged with Dexmeditomidine, making its use in the day  
 
care setting again, doubtful(63). 
 
 
Baik et al found that intravenous injection of Lignocaine 1.5mg/kg prior to Propofol  
target controlled infusion improved insertion conditions. 
 
In 2012 now, Gabapentine is the latest agent to be studied to reduce the fasciculation and  
 
succinycholine induced myalgia as succinylcholine is still one of the best agents to facilitate  
 
Laryngeal Mask Airway insertion.   
.  
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MATERIALS AND METHODOLOGY 
 
This is a double blinded randomized control trial done on 283 patients. The study was  
predominantly done in the day care theatre, as this is where most number of Laryngeal Mask  
Airways are used in a day. The required sample size to show a difference in the insertion  
conditions was found to be 92 in each group with an anticipated proportion of insertion  
conditions as 30%, 10% and 15% respectively with 80% power and 1% level of significance  
(this is done for three group comparisons). 
 
𝑛 =
 𝑍𝛼/2 + 𝑍1−𝛽 
2
2 ∗ 𝑃𝑄
𝑑2
 
 
Required sample size for each arm was 92. Values were taken from the „overall insertion  
conditions‟ table in the study “ A comparison of Midazolam and mini dose Succinylcholine to  
aid Laryngeal Mask Airway insertion during Propofol anaesthesia” by Wafaa Taha Salem(3).   
 
     Patients were not premedicated. All cases were in the elective setting. Surgeries  
requiring general anaesthesia using the Laryngeal Mask Airway were included, such as  
exploration under anaesthesia and lay open fistulae, lipoma excision, wide local excision of 
breast lump, implant removal, skin grafting, cystoscopy, circumcision, tympanoplasty etc. 
Patients included were ASA I and II, age between 20 and 65 requiring general anaesthesia using 
a Laryngeal Mask Airway. Patients excluded were ASA > II, age < 20 or > 65, BMI > 30, 
difficult airways, oral surgery.  
 
 Informed consent was taken from all patients. Patients were preoxygenated with 100%  
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oxygen. 2mg/kg of Propofol was given over a constant rate over 30 seconds after 2μg/kg of  
Fentanyl. Adequacy of anaesthesia was assessed by loss of eye lash reflex. If this dose of  
Propofol was not adequate further boluses of 0.25mg/kg were given every 15 seconds till depth  
was adequate. The study drug was given after the eyelash reflex was abolished. 
 
 A computer block randomization was used to allocate patients into three groups,  
Placebo (groupI), 0.1mg/kg (groupII) and 0.25mg/kg (group III) of Succinylcholine. The method  
of allocation concealment was using opaque envelopes with serial numbers. The person  
administering the drug would choose the appropriate syringe out of three which was loaded by  
the anaesthetist; according to what was mentioned in the envelope.  
 
The classic Laryngeal Mask Airway was inserted 60 seconds after the study drug was  
given using the standard method of insertion. Patients were assessed for jaw relaxation,  
coughing, gagging, laryngospasm and overall insertion conditions. Number of attempts at  
insertion and total Propofol consumption were also recorded, as were duration of apnoea,  
haemodynamics, presence of fasciculations and post operative myalgia. Pre induction heart rate,  
systolic blood pressure, diastolic blood pressure, mean arterial blood pressure and saturation  
were recorded. The same were recorded post induction and post insertion.  
 
If insertion was not possible at the first attempt, anaesthesia was maintained with 2% of  
Isoflurane, an additional dose of 1mg/kg of Propofol was given and insertion attempted 30  
seconds later. 1mg/kg of Propofol was repeated as and when necessary.  
 
Patients were monitored using standard methods of monitoring with the  
electrocardiogram, non invasive blood pressure, pulse oximetry and end tidal carbon di oxide.  
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Intra operative anaesthesia was maintained using oxygen and nitrous oxide 50:50, and Isoflurane  
1%. Intraoperative use of analgesics was standardized. 0.1mg/kg of Morphine intra venous and  
1gm of Paracetamol intra venous was administered to all patients. If the anaesthesiologist felt  
that the patient required additional analgesia either intra operatively or post operatively, it was  
administered, and noted down in the data collection form. Patients were examined for myalgia at  
two hours and four hours post operatively. Post operative myalgia on the following days could  
not be assessed as this was in the day care setting.  
  
Assessment was made using different standard criteria(3). Jaw relaxation was according  
to the criteria of Young et al- namely good, incomplete and poor. Coughing and gagging- none,  
mild, moderate, severe; laryngospasm-none, partial, total; patient movement- none, mild,  
moderate, severe, according to Nimo et al. Overall insertion conditions were assessed according 
 to the modified scheme of Lund and Stovner- excellent- insertion easy, no gagging, coughing,  
movement or laryngospasm; good-insertion resulting in mild to moderate coughing, gagging,  
movement with no laryngospasm; poor- insertion possible but resulting in moderate to severe  
coughing, gagging, patient movement with no laryngospasm; and unacceptable- severe  
coughing, gagging, movement or laryngospasm. Scoring of Laryngeal Mask Airway insertion  
was performed only for the first attempt at insertion. 
  
Statistical analysis was performed using analysis of variance (ANOVA) with  
Bonferroni‟s t test and Chi square test to compare groups and calculate duration of apnoea.  
Fischer‟s exact test was used to assess insertion conditions, fasciculations and myalgia. A p value  
of < 0.05 was considered significant.  
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RESULTS 
The following results were obtained from the study. Group I refers to placebo which was saline,  
Group II refers to 0.1mg/kg of Succinylcholine and Group III refers to 0.25mg/kg of  
Succinylcholine. 
 
1) Adequate sample size was attained with a total of 283 patients. Informed consent was  
taken from all patients. Group I and II had 95 patients each, and Group III 93 patients. All  
patients were ASA I or II. None of the patients had a difficult airway. 
 
Demographic  Data 
  Placebo- saline 
(groupI) 
 
0.1mg/kg  
Succ innylcholine 
(groupII)  
0.25mg/kg 
Succinylcholine  
(groupIII)  
 
No Of Patients- n 
(%) 
95 (33.6%) 95 (33.6%) 93 (32.9%) 
 
 
 
 
 
Placebo
33.6%
SCh 0.1
33.6%
SCh 0.25
32.9%
Patients in each Arm
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2) Demographically all groups were equally distributed in terms of age, weight, height  
 
and BMI. 
      Age 
 
 
Mean age was 37 to 40 and was equally distributed in all three groups. 
 
 
 
 
 
 
 
 
37 37.5 38 38.5 39 39.5 40
Placebo
SCh 0.1
SCh 0.25
Mean Age
Mean Age
 Placebo- saline 
(groupI) 
 
0.1mg/kg  
Succ innylcholine 
(groupII) 
0.25mg/kg 
Succinylcholine  
(groupIII)  
 
 
Age(yr) -  mean(+/- 
SD) 
40 (12) 38 (12) 39 (12) 
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Demography 
   Weight, height and BMI 
 
The average BMI in all three groups was 23- 24.  
 
 
 
23.2
23.4
23.6
23.8
24
24.2
24.4
24.6
Placebo SCh 0.1 SCh 0.25
BMI 
 Placebo- saline 
(groupI) 
 
0.1mg/kg  
Succ innylcholine 
(groupII) 
0.25mg/kg 
Succinylcholine  
(groupIII)  
 
Weight(kg)– 
mean(+/- SD) 
66 (12) 64 (13) 64 (11) 
 
 
Height(cms)– 
mean(+/- SD) 
163 (9.5) 164 (9.3) 162 (9.1) 
 
 
BMI – mean(+/- SD) 24.4 (4) 23.7 (4.5) 24.5 (3.7) 
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3) Sex ratio 
 Placebo- saline 
(groupI) 
 
0.1mg/kg  
Succ innylcholine 
(groupII) 
0.25mg/kg 
Succinylcholine  
(groupIII)  
 
 
Sex- M:F  n 
(%) 
64:31 (67.4%:32.6%) 70:25 (73.7%:26.3%) 61:32 (65.6%:34.4%) 
 
 
 
 
 
The male to female ratio was equal in all three groups, though there were more males  
than females in each group. 
 
    Sex ratio 
 
 
 
 
 
 
0
10
20
30
40
50
60
70
80
Placebo SCh 0.1 Sch 0.25
MALE
FEMALE
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4) Conditions during LMA insertion- jaw relaxation 
Conditions during LMA insertion-jaw relaxation 
 Placebo- saline 
(groupI) 
0.1mg/kg  
Succ innylcholine 
(groupII) 
0.25mg/kg 
Succinylcholine  
(groupIII) 
Jaw Relaxation (p- 
0.026) 
 
Good- n (%) 56 (58.9%) 60 (63.2%) 71 (76.3%) 
 
Incomplete- n (%) 37 (38.9%) 29 (30.5%) 21 (22.6%) 
 
Poor- n (%) 2 (2.1%) 6 (6.3%) 1 (1.1%) 
 
 
On looking at conditions during Laryngeal Mask Airway insertion; jaw relaxation  
was significantly better in Group III, with a p value of 0.026. It was also seen that jaw  
 
relaxation was incomplete in close to 40% of the patients in the 0.1mg/kg  
 
Succinylcholine group.  
Jaw relaxation  
 
       
0
20
40
60
80
100
120
Placebo SCh 0.1mg/Kg SCh 0.2mg/Kg
Poor
Incomplete
Good
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5) Conditions during LMA insertion- coughing and gagging 
 
Gagging, Cough (p-
0.59) 
 
 
None- n (%) 86 (90.5%) 90 (94.7%) 90 (96.6%) 
 
Mild- n (%) 5 (5.3%) 4 (4.2%) 2 (2.2%) 
 
Moderate- n (%) 3 (3.2%) 1 (1.1%) 1 (1.1%) 
 
Severe- n (%) 1 (1.1%) 0 (0.0%) 0 (0.0%) 
 
 
There was no statistically significant difference in the incidence of coughing and  
gagging between all three groups, though clinically there was more in the Placebo group. 
 
 
coughing and gagging 
 
 
 
84
86
88
90
92
94
96
98
100
102
Placebo SCh 0.1mg/Kg SCh 0.25mg/Kg
Severe
Moderate
Mild
none
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5) Conditions during LMA insertion- patient movement 
 
Patient movement 
(p- 0.018) 
 
None- n (%) 69 (72.6%) 83 (87.4%) 84 (90.3%) 
 
Mild- n (%) 11 (11.6%) 8 (8.4%) 6 (6.5%) 
 
Moderate- n (%) 11 (11.6%) 3 (3.2%) 2 (2.2%) 
 
 
Severe- n (%) 4 (4.2%) 1 (1.1%) 1 (1.1%) 
 
 
There was significantly more patient movement in the Placebo group, with a p value  
 
of 0.018. Group II and III had similar values. 
 
Patient movement  
 
 
 
 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Placebo SCh0.1mg/Kg SCh0.25mg/Kg
Severe
Moderate
Mild 
None
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6) Only two patients in the Placebo group experienced partial laryngospasm. None of  
 
the other patients had laryngospasm.  
 
Laryngospasm (p- 
0.136) 
 
None- n (%) 93 (97.9%) 95 (100%) 93 (100%) 
 
Partial- n (%) 2 (2.1%) 0 (0.0%) 0 (0.0%) 
 
Total 0 (0.0%) 0 (0.0%) 0 (0.0%) 
 
 
Laryngospasm 
 
       
 
 
 
 
Placebo
None
Partial
Total
SCh 0.1mg/Kg
None
Partial
Total
SCh 0.25mg/Kg
none
Partial
Total
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7) Overall insertion conditions 
 
OVERALL  INSERTION 
CONDITIONS (p- 0.003) 
Excellent  
 
63 (66.3%) 78 (82.1%) 79 (84.9%) 
 
Good 
18 (18.9%) 6 (6.3%) 11 (11.8%) 
 
Poor 
10 (10.5%) 4 (4.2%) 1 (1.1%) 
 
Unacceptable 
4 (4.2%) 7 (7.4%) 2 (2.2%) 
 
Overall insertion conditions were evidently better in Group III with a p value of 0.003. 
Though excellent insertion conditions were seen in 82% of Group II, this group had a 
higher number of unacceptable insertion conditions, compared to Group I. This helps us 
conclude that 0.1mg/kg of Succinylcholine is not sufficient to aid smooth insertion of the 
Laryngeal Mask Airway. 
overall insertion conditions  
 
0
20
40
60
80
100
120
Placebo SCh 0.1mg/Kg SCh 0.2mg/Kg
Unacceptable
Poor
Good
Excellent 
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8) Insertion attempts- In most patients the Laryngeal Mask Airway was inserted in 
the first attempt, 264 out of 283 patients. Only 18 patients required two attempts 
and only one patient required three attempts. Thus statistically there was no 
difference in number of insertion attempts. Most often the Laryngeal Mask Airway 
was inserted, there would be patient reaction, and an additional dose of Propofol 
would be given. Most cases would settle with the Laryngeal Mask Airway well in 
place, not requiring a second attempt at insertion. Out of the 18 patients that 
required a second attempt, there were 8 each from Group I and Group II, and only 2 
from Group III. 
Total insertion attempts 
 Placebo - saline 
(groupI) 
 
0.1mg/kg  
Succ innylcholine 
(groupII) 
0.25mg/kg 
Succinylcholine  
(groupIII) 
No of insertion 
attempts mean(+/- 
SD) p- 0.27 
1 (0.27) 
 
1 (0.27) 1 (0.25) 
 
 
 
 
               
8
8
2
second attempt at insertion (n- 18)
placebo
0.1 mg/kg Sch
0.25 mg/kg
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9) Total Propofol requirement  
 
Total dose of Propofol  in each group 
 Placebo- saline 
(group I) 
0.1mg/kg  
Succ innylcholine 
(groupII) 
0.25mg/kg 
Succinylcholine  
(groupIII) 
Total dose– median 
(IQR) p- 0.024 
 
140 (120- 160) 135 (110-150) 130 (120- 145) 
 
Significantly more in the Placebo group with a p value of 0.024.  
 
 
propofol consumption  
 
 
124
126
128
130
132
134
136
138
140
142
PLACEBO S Ch 0.1mg/kg S Ch 0.25mg/kg
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Propofol consumption in mg/kg  
 Placebo- saline 
(group I) 
0.1mg/kg  
Succinylcholine 
(groupII) 
0.25mg/kg 
Succinylcholine  
(groupIII) 
Propofol 2mg/kg 
 n (%) 
77 (81.1%) 84 (88.4%) 88 (94.6%) 
Propofol 3mg/kg  
n (%) 
18 (18.9%) 11 (11.6%) 5 (5.4%) 
 
Most patients required 2mg/kg of Propofol, but out of those requiring 3mg/kg most 
were from the placebo and 0.1mg/kg Succinylcholine group. 249 patients of 283 
required 2 mg/kg, and 34 needed 3 mg/kg. 
Propofol consumption in mg/kg 
 
81.10%
88.40%
94.60%
18.90%
11.60%
5.40%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
placebo 0.1mg/kg Sch 0.25mg/kg Sch
3mg/kg
2 mg/kg
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10) Haemodynamics and Oxygen Saturation in each group 
 
 Placebo- saline 
(groupI) 
0.1mg/kg  
Succ innylcholine 
(groupII) 
0.25mg/kg 
Succinylcholine  
(groupIII) 
Systolic blood pressure (mm 
Hg)  mean(+/- SD) 
Pre-Induction (p-0.205) 132 (21.1) 129 (15.9) 134 (18.3) 
 
Post-Induction (p-0.019) 103 (15.2) 102 (13.9) 108 (16.3) 
 
Post-Insertion (p-0.166) 101 (16.0) 97 (11.5) 99 (12.4) 
 
Diastolic blood pressure (mm 
Hg) 
– mean(+/- SD) 
Pre-Induction (p-0.345) 77 (10.6)  75 (13.3) 78 (13.1) 
 
Post-Induction (0.044) 61 (12.4) 58 (12) 63 (14) 
 
Post-Insertion (p-0.303) 59 (11.5) 57 (11.30 56 (10.8) 
 
Mean arterial blood (mm Hg) 
pressure – mean(+/- SD) 
Pre-Induction (p-0.226) 90 (11.1) 88 (12.4) 90 (12.8) 
 
Post-Induction (0.013) 71 (12.5) 68 (11.6) 74 (13.5) 
 
Post-Insertion (p-0.279) 69 (11.5) 66 (11) 67 (11.4) 
 
Heart rate (bpm) – mean(+/- 
SD) 
 
Pre-Induction (p- 0.354) 84 (15.6) 
 
85 (15.9) 87 (14.8) 
Post-Induction (p-0.909) 77 (14.3) 
 
77 (13.1) 78.3 (12.9) 
Post-Insertion (p-0.789) 73 (12.0) 
 
72 (12.0) 73 (12.8)  
SpO2% – mean(+/- SD) 
 
Pre-Induction (p-0.845) 99 (1.1) 99 (1.1) 
 
99 (0.9) 
Post-Induction (p-0.332) 99 (0.3) 99 (0.9) 99 (0.5) 
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Post-Insertion (p-0.841) 99 (0.8) 99 (0.9) 
 
99 0.7) 
 
 
There were no statistically significant differences in haemodynamics between the  
groups.  
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11) As haemodynamics were not different, the use of vasopressors was not  
significantly different between the groups. 
 
 
Use of Vasopressors 
 
 
 
Placebo- saline 
(groupI) 
0.1mg/kg  
Succ innylcholine 
(groupII) 
0.25mg/kg 
Succinylcholine  
(groupIII) 
n (%) p- 0.474 
 
9 (9.5%) 11 (11.6%) 6 (6.5%) 
 
 
 
 
 
 
9.50%
11.60%
6.50%
use of vassopressors
placebo
0.1mg/kg
0.25mg/kg
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12) Duration of apnoea- Average duration of apnoea was 5-6 minutes. There was no 
clinically significant difference in the duration of apnoea between the groups. This 
could be because the placebo group required significantly more Propofol.   
 
Duration of apnoea 
 
 Placebo - saline 
(groupI) 
 
0.1mg/kg  
Succ innylcholine 
(groupII) 
 
0.25mg/kg 
Succinylcholine  
(groupIII) 
Apnea duration (min) 
Median (IQR) p- 0.502 
6 (0-25) 
 
5 (0-30) 5 (0-30) 
 
 
 
 
 
 
 
 
 
 
6min
5min
5min
duration of apnoea
placebo
0.1mg/kg
0.25mg/kg
75 
 
 
13) Fasciculations were more in Group III.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.5%
49.5%
69.9%
fasciculations
placebo
0.1mg/kg
0.25mg/kg
 Placebo - 
saline 
(groupI) 
 
 
0.1mg/kg  
Succinnylcholine 
(groupII) 
 
0.25mg/kg 
Succinylcholine  
(groupIII) 
n (%) 2 (2.5%) 
 
47 (49.5%) 65 (69.9%) 
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14) Only one patient in Group II complained of myalgia after two hours. Two patients 
in  
 
Group I complained of myalgia after four hours.  
 
 
 
Myalgia after 2 hours 
 
 Placebo - saline 
(groupI) 
 
 
0.1mg/kg  
Succ innylcholine 
(groupII) 
0.25mg/kg 
Succinylcholine  
(groupIII) 
 
 
n (%) p (0.37) 0 (0%) 
 
1 (1.1%) 0 (0%) 
 
 
 
 
 
     Myalgia after 4 hours 
 
 Placebo - saline 
(groupI) 
 
 
0.1mg/kg  
Succ innylcholine 
(groupII) 
0.25mg/kg 
Succinylcholine  
(groupIII) 
 
 
n (%) p (0.13) 2 (2.1%) 
 
0 (0%) 0 (0%) 
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15) Intraoperative analgesia was standardized for all patients so that it would not  
 
confound results of post operative myalgia. If the anaesthesiologist felt the patient  
 
required more analgesia it was given and recorded. There was no statistically  
 
significant difference in the amount of additional analgesia given. Hence it was not a  
 
confounding factor towards postoperative myalgia.  
 
 
 
 
 
Intraoperative analgesia 
 
 
 
 
Placebo - saline 
(groupI) 
 
0.1mg/kg  
Succ innylcholine  
(groupII) 
0.25mg/kg 
Succinylcholine  
(groupIII) 
 
 
n (%) p  
 
15 (15.8%) 19 (20%) 11 (11.8%) 
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DISCUSSION 
 Christian Medical College is a tertiary level teaching centre that caters to 5000 out 
patients a day, and has 2600 inpatient beds. Surgical specialties do 2000 surgeries a month. Our 
ambulatory surgery center was set up in the year 2000. There are two operating theatres, each 
comprising of a well set up anaesthesia work station. On an average 350- 400 cases are done in a 
month. The departments of general surgery, vascular surgery, endocrine surgery, hepatobiliary 
surgery, colorectal surgery, orthopaedics, urology and otorhinolaryngology operate every week.  
Most of these are under general anaesthesia using the Laryngeal mask Airway as regional or 
neuraxial anaesthesia is asscociated with slower recovery and discharge(64). The main theatre 
complex in this hospital has thirty two operating theatres. Here too the Laryngeal Mask Airway 
is used in several surgeries. In fact around the world the use of the Laryngeal Mask Airway is 
becoming more and more common for numerous different surgeries. Hence the relevance of this 
study.  
 Propofol is the induction agent of choice in Laryngeal Mask Airway placement as it 
blunts the laryngeal reflexes (33). The disadvantage of using Propofol alone is excessive patient 
movement and coughing and gagging. This leads to additional Propofol usage and thus 
hypotension and prolonged duration of apnoea. Wafaa et al found that failed insertion attempts 
of Laryngeal Mask Airway placement were due to coughing and gagging in 75% of patients 
when only Propofol was used (3). Successful insertion at first attempt was only 60%.  
 Numerous adjuvants have been and are still being studied to facilitate Laryngeal Mask 
Airway insertion. Benzodiazepines are known to reduce upper airway reflexes(65). Midazolam 
has been studied more than once (3), (66). Wafaa found that 0.04mg/kg of Midazolam helped 
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reduce the Propofol dose by 40%. Thus there was less hypotension and more cardiovascular 
stability. The disadvantage of Midazolam is its sedative effect and particularly in the ambulatory 
setting this may cause delayed discharge.  
   Other agents that have been studied  like Clonidine(56) and  Dexmeditomidine(63) all 
which have some benefit but sedation would be an issue in the ambulatory surgery setting and 
costs and availability too need to be looked into.  
Relatively newer Opioids such as Alfentanyl, Remifentanyl and Butorphanol are also 
being studied but duration of apnoea, hypotension, post operative nausea, vomiting and 
availability are issues to be dealt with(55)(58)(62)(61). 
 Ketamine provided stable haemodynamics and less duration of apnoea and was found to 
be more useful in the difficult airway setting(59)(66)(60). 
.   Since relaxation of the muscles of the airway is what would enable smooth insertion, a 
muscle relaxant would be the best agent to serve this purpose. The ideal muscle relaxant for use 
in the ambulatory setting is still in search(67),(68),(64). Muscle relaxants avoid side effects like 
hypotension and sedation. 
 Non depolarizing muscle relaxants like Mivacurium and Rocuronium have been 
studied(4)(54). The effects of residual neuromuscular blockade always remain a concern with 
non depolarizing agents, especially in the day care setting. The use Neostigmine and the nerve 
stimulator are implicated if non depolarizing agents are being used. Use of Neostigmine can be 
associated with increased incidence of post operative nausea and vomiting. . Suggamedex as the 
answer to the problem is being hoped for.  
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Depolarizing agents like Succinylcholine are still widely used because of its quick onset, 
short duration, and excellent intubating conditions(68). It is easily available, inexpensive, a time 
tested drug, and has no sedative side effects. The usual induction dose is 1- 2 mg/kg (7). Side 
effects include apnoea, anaphylaxis and myalgia. Lower doses have less of these side effects. 0.1 
mg/kg of Succinylcholine is known to relieve laryngospasm (69) and does not cause increased 
duration of apnoea. To date none of the studies done on low dose Succinylcholine compare two 
different doses to estimate the ideal dose for smooth insertion of the Laryngeal Mask Airway.   
Yoshino et al did such a study comparing 0.25mg/kg and 0.5mg/kg Succinylcholine, with 
Thiopentone as the induction agent. 0.5 mg/kg Succinylcholine had higher incidence of side 
effects like fasciculations, myalgia and apnoea (6). Most studies compare another agent such as 
Midazolam, or Fentanyl with Succinylcholine. In our study we look at 0.1 mg.kg and 0.25mg/kg 
of Succinylcholine. Most studies have a sample size of 60-150. In this study 283 patients were 
included.  
 283 patients were equally distributed in all three groups- Placebo, 0.1mg/kg of 
Succinylcholin and 0.25mg/kg of Succinylcholine. There were 95 patients each in the placebo 
and 0.1mg/kg group, and 93 patients in the 0.25mg/ kg group. This was adequate to power the 
study well  as according to the sample size calculation each arm required 92 patients. 
Demographically patients were equally distributed in terms of age, weight, height and BMI. 
Overall there were more males than females. This is probably because patients coming for 
Urological procedures were mainly male. Anorectal rectal disorders are more in males than 
females with ratio of 70%:30% (70). A lot of patients included in the study came for anorectal 
procedures. This is also one of the reasons for males than females. 
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 Jaw relaxation was clearly better in Group III. Group II had quite a high incidence of 
incomplete and poor jaw relaxation. This helps us infer that 0.1mg/of Succinylcholine is 
probably not sufficient and 0.25mg/kg is better for adequate jaw relaxation. There was no 
significant difference in the incidence of coughing and gagging between all three groups. 
Clinically there were more numbers in the Placebo group, though not statistically significant. 
Patient movement was significantly more in the Placebo group. This was the most common 
reason for additional Propofol requirement. Laryngospasm was not experienced by any patient; 
there was partial laryngospasm in only two patients in the Placebo group. This is probably 
because of the uniform use of 2mg/kg of Propofol which blunts laryngeal reflexes.  
 Overall insertion conditions were clearly better in the Group III, both clinically and 
statistically. Group II had similar values to Group III in the „excellent‟ insertion conditions 
group, and had 6.3% and 4.2% of patients who had „good‟ and „poor‟ insertion conditions 
respectively. Surprisingly Group II had more patients in with „unacceptable‟ insertion conditions, 
due to inadequate jaw relaxation and patient movement; 7.4% compared to even the Placebo 
group, which had only 4.2%. One explanation could be that there was more patient movement in 
the Placebo group during attempts to open the jaw hence an additional dose of Propofol was 
given before attempting insertion itself. In the Group II the first signs of inadequate dose were 
during insertion of the Laryngal Mask Airway itself and that is probably why this group had a 
higher number of unacceptable insertion conditions. We infer again that 0.1mg/kg of 
Succinylcholine is not sufficient to facilitate smooth insertion of the Laryngeal Mask Airway.  
 Number of insertion attempts was not statistically significant, most requiring one attempt.  
The number of patients requiring more than one insertion attempt was 19, of which 18 needed 
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two attempts. Of these there were eight each from Group I and II, showing us that number of 
insertion attempts was clinically more in these groups, though not statistically significant.  
 
 Total Propofol consumption was significantly more in the Placebo group. Most patients 
in the study required 2mg/kg of Propofol, but 12% required 3mg/kg of which 60% were from the 
placebo group and 32% from the 0.1mg/kg group. This again shows us that clinically more 
patients in these groups required more propofol, though statistically not significant. 
 Haemodynamic stability was similar in all groups. Though a large drop in blood pressure 
was expected in the placebo group because they required more Propofol, they were found to be 
stable. Only 26 in the entire 283 patients required a vasopressor, Ephedrine 6mg to restore the 
blood pressure, most often after insertion of the Laryngeal Mask Airway.  
 Duration of apnoea was the same in all groups. The Placebo group though expected to 
have a shorter duration of apnoea had duration similar to the Succinylcholine groups. This is 
probably because of the increased Propofol consumption.  
 Fasciculations were more in the Group III. Some patients in the 0.1mg/kg group did not 
have fasciculations. There were two patients in the Placebo group who had „fasciculations‟, these 
were probably involuntary movements that can occur with Propofol, and were interpreted as 
fasciculations. 
 The incidence of myalgia was very low. Lately it has been observed that myalgia is 
common after ambulatory surgery and the causes are multifactorial. The incidence of myalgia is 
highest in the first 24 hours, but does occur even afterwards (38). One study by Yoshino et al 
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showed a higher incidence of myalgia on the third post operative day. In this study myalgia 
patients were checked for myalgia 2 hours and 4 hours post operatively as they were discaharged 
on the same day. Myalgia was seen in one patient in Group II after 2 hours and two patients in 
the Placebo group after 4 hours. This too may advocate the multifactorial cause of myalgia. 
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CONCLUSIONS 
 
This study concludes that a low dose of Succinylcholine does facilitate insertion of the 
Laryngeal Mask Airway. The ideal dose is 0.25mg/kg of Succinylcholine. 0.1mg/kg is not 
sufficient and is associated inadequate jaw relaxation and does not always provide smooth 
insertion conditions. There is decreased Propofol consumption with use of Succinylcholine. 
Haemodynamics were not affected adversely. Duration of apnoea is not unduly prolonged and 
was the same in all groups. Fasciculations were more in the 0.25mg/kg group but there was no 
relation between fasciculations and myalgia, reinstating the multifactorial basis behind myalgia.  
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LIMITATIONS 
 
1) Though the primary investigator was blinded, fasciculations was sometimes a 
confounding factor. All cases using Succinylcholine especially 0.1mg/kg did not have 
fasciculations, so it was not necessarily known whether Succinylcholine was used or not. 
2) Myalgia was assessed only at two and four hours. There may have been more myalgia 
later than this period. 
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I) INFORMATION SHEET 
 
     This is a study that is validating the use of succinyl choline facilitating the LMA 
insertion. 
The patient will be undergoing a surgical procedure requiring general anaesthesia 
which will be administered in this case by LMA ( Laryngeal Mask Airway). This is a 
simple and safe procedure. Here the airway which looks like a tube is inserted 
through the mouth and oral cavity and rests over the respiratory passage. In normal 
conditions after induction (putting the patient into a deep sleep), the LMA is inserted 
directly without any muscle relaxant. However there can be some difficulty during 
the insertion of the LMA as the oral and pharyngeal musculature can be tight. 
    This study asseses the benefit of using Succiny choline in facilitating LMA 
insertion. 
Succinyl choline is a drug which has been widely used in anaethetic practice. It is a 
muscle relaxant that is used to relax the pharyngeal (throat) and laryngeal (vocal 
chords) muscles. It is often used during general anaesthesia requiring endotracheal 
intubation. Here in this study the drug will be administered after putting the patient to 
sleep and soon after the LMA will be inserted. Vital parameters such as heart rate, 
blood pressure etc will be monitored during the surgery. Post operatively side effects 
will be assessed. 
    It is vital to note that as this is blinded study the patient may not receive the actual 
drug and might only receive a placebo (normal saline) injection. There are no 
associated risks with this. The common side effects of Succinylcholine are 
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fasciculations, postoperative body pain and it is not used in patients with burns and 
paralysis due to severe side effects. 
     The potential benefit of using SC can be easier insertion of the LMA, facilitating 
better anaesthesia, lesser soft tissue trauma, reduced post operative pain and voice 
problems. 
The patient has every right to refuse participation in the study but cannot decide 
which drug he will receive ( SC or NS). 
Participation is voluntary and the patient can withdraw from the study at any time and refusal    
to participate will not involve any penalty or loss of benefits to which otherwise entitled. 
All data and vital statistics obtained in this study will be confidential and will be maintained 
by the principal investigator. 
There will be no compensation and/or treatment available to the subject in the event of a 
study-related  injury 
For any further queries: 
Contact  
Dr. Leah Maria Raju, 
Dept of Anaesthesiology, 
CMCH. 
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II) CONSENT FORM 
Low dose Succinylcholine to facilitate LMA insertion 
                                                                                                                            
                                                                                                                                     
                                                                                                                                             Date: 
Patient‟s Name:      
Patient‟s Initials:  
Hospital No. 
Date of Birth / Age: 
 
(i) I confirm that I have read and understood the information sheet dated _________ for the 
above study and have had the opportunity to ask questions. [ ] 
(ii) I understand that my participation in the study is voluntary and that I am free to withdraw at 
any time, without giving any reason, without my medical care or legal rights being affected. [ ] 
(iii) I understand that the Sponsor of the clinical trial, others working on the Sponsor‟s behalf, 
the Ethics Committee and the regulatory authorities will not need my permission to look at my 
health records both in respect of the current study and any further research that may be 
conducted in relation to it, even if I withdraw from the trial. I agree to this access. However, I 
understand that my identity will not be revealed in any information released to third parties or 
published. [ ] 
(iv) I agree not to restrict the use of any data or results that arise from this study provided such a 
use is only for scientific purpose(s) [ ] 
(v) I agree to take part in the above study. [ ] 
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Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
Signatory‟s Name: _________________________________ 
 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator‟s Name: _________________________ 
 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: ______________________________ 
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                                DATA COLLECTION SHEET  
Name-                                                                             Surgery- 
Hospital number- 
Age- 
Weight-                     Height-                    BMI-  
ASA Grade-  
Airway-                     Mallampati-                        Teeth-                       Neck extension    
ASSESMENT 
1) jaw relaxation- 
2) coughing or gagging 
3) patient movement- 
4) laryngospasm- 
5) overall insertion conditions- 
6) total insertion attempts- 
7) total Propofol requirement-    ---------- mg  (---------mg/kg) 
8) haemodynamics 
 pre induction post induction post insertion 
Heart rate    
BP (MAP)    
SpO2    
         Use of vasopressors-    Drug-                      Dose-  
9) apnoea duration- 
10) fasciculations-  
11) myalgia-   2hrs-                     4hrs 
12) additional analgesia- intra op                                   post op 
 
 
DRUG- 
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IV) DATA SPREAD SHEET 
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AUDIT- ADEQUACY OF INTRA OPERATIVE TIME OUT PROCEDURE 
INTRODUCTION 
One of the sentinel events in medical practice that can be wholly avoided is the 
predicament of wrong site, wrong procedure and wrong person surgery.Wrong-site surgery is 
defined as an operation conducted at the wrong site, on the wrong person, or resulting in the 
wrong procedure(1). Since the early nineties reports of wrong side, site, patient, procedure or 
implant have been reported. Such incidents continue to occur and numerous organizations have 
identified the problem and come up with protocols. The Second Global Patient Safety Challenge 
initiative by the WHO was Safe Surgery Saves Lives. This addressed the issue of safety of 
surgical care. The World Alliance for Patient Safety began work on this challenge in January 
2007. The focus of the Challenge was the WHO Safe Surgery Checklist. The checklist was 
divided into three phases. The first, “sign in” is done before the induction of Anaesthesia, the 
second, “time out” is done just before the incision is made, and the third, “sign out” is done 
before the patient leaves the operating room. Our institution follows these guidelines. This audit 
was done on the first phase, “sign in”(2). 
The American Joint Commission Board of Commissioners issued two Sentinel Event 
Alerts, one in 1998 and a follow up in 2001. As a reaction to numerous reports of wrong side, 
site, procedure and patient events, they hosted a Wrong Site Surgery Summit and along with 
many other key organizations came up with the Universal Protocol for Preventing Wrong Site, 
Wrong Procedure and Wrong Person Surgery in July 2003. This became effective in July 
2004(3). 
In 2003 the National Patient Safety Agency advocated side marking to avoid errors.  
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AUDIT SCOPE 
Even in 2012 the search for methods to reduce the incidence of wrong site, side and 
patient are still on. The Urologists of University of Michigan Medical School, Ann Arbor came 
up with a radio opaque stickers labeled R or L that were stuck preoperatively and could be 
identified during intra operative fluoroscopy for upper tract endoscopic procedures(4).Mahar et 
al did a comprehensive electronic data base search and highlighted the findings of one 
interrupted time series (ITS) study(5). This study concluded that specific educational 
interventions which included a training session for junior staff, exposing them to reports of 
previous wrong side/ site surgeries and guidelines, helped reduce wrong site surgery. Wu et al 
published that scheduling errors also added to the risk of wrong side/ site surgery apart from 
increasing costs and disruption of operating room dynamics and delays (6).  
 These errors continue to occur at an alarming rate. It was the most frequently reported 
sentinel event in 2009 and the third most reported sentinel event in 2010. Though the exact 
incidence and prevalence is difficult to ascertain, the Joint commission estimated a national 
(USA) incidence as high as 40 per week (6). This is quite a disturbing number and indicates that 
the problem is a reality and there is scope for improvement. Methods to stop these mishaps 
should be taken seriously.   
APPROACH AND METHODOLOGY 
A data collection sheet was devised based on the institutions surgical safety checklist. 
This was distributed to anaesthesiologists in different operating rooms of various surgical 
specialties who observed if the “sign in” was done correctly or not. The surgeons and nurses 
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23
1
patient identity 
confirmed with OP chart
yes
were not aware of this. This was done over a period of two weeks.  101 cases were entered and 
analyzed.  
AUDIT FINDINGS 
101 cases were included in the audit, from different specialties.  
       
        
 
Was the patient identity confirmed with  
the Out Patient chart?  
 
 
 
 
no
40% 
(40)
yes
60% 
(61)
pateint identity asked
84
16
1
identity confirmed with 
ID band
yes
no
not 
entered
Was the patient asked his/her name?                  
 
Was the patient identity confirmed with the 
identity band?  
 
n = 101 
n = 101 
n = 101 
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Was the patient not spoken to and only the 
ID band and chart correlated? 
 
 
     Was the operation side marked ? 
 
 
 
 
Procedure confirmed with the patient? 
 
 
 
 
 
       Checklist signed by nurse? 
 
 
 
 
 
 
38
60
3
only ID band and OP chart 
correlated
yes
no
not entered n = 101 
43
12
46
operation side marked
yes
no
not applicable
n = 101 
37
60
4
procedure confirmed with the 
patient
yes
no
not 
entered
n = 101 
79
18
4
checklist signed by nurse
yes
no
not entered
n = 101 
6 
 
 
Checklist signed by surgeon? 
 
  
 
 
Checklist signed by anaesthesiologist? 
 
 
 
 
Time out done before anaesthetic given? 
 
 
 
 
Were the surgeons present during time out?  
 
34
56
11
checklist signed by surgeon?
yes
no
not entered
n = 101 
54
43
4
checklist signed by 
anaesthesiologist
yes
no
not entered
n = 101 
69
30
4
time out done before 
anaesthetic was given
yes
no
not entered
n = 101 
77
24
surgeons present?
yes
no
n = 101 
7 
 
In cases where the surgeon was absent,  
was it the first case or not? 
 
RECOMMENDATIONS 
As seen in the audit findings, the patient is often not spoken to to confirm name and 
procedure. The nurses sign the check list in most cases though. The surgeons and 
anaesthesiologists lag in this field. Surgeons were present most of the time during the „sign in‟, 
though when they were not it was the for the first case half the times.  
We recommend that the importance of this check list be made known to all by regular 
training sessions that emphasise on mistakes made in the past. As an anaesthesiologist and a 
leader of the team, we may choose not to start a case until the „sign in‟ is done in the correct 
manner, so that it becomes a habit for all. The findings of tis audit may be made known to the 
operatig room personnel and a reaudit can be done. During following audits if it is found that the 
checklist is not signed, it can be recommended that the concerned professional be penalised. 
CONCLUSIONS 
 We conclude that presently the intra operative check list is not being followed in the 
correct manner. Patients are not being spoken to quite often and  this can pose a great risk in the 
false identification of a patient. The surgeons, anaesthesiologists and  nurses must each  inculcate 
the habit and take upon the responsibility to ensure that this basic protocol is followed.  This will 
also put the patient at ease and  improve the overall functioning of the operating room. 
 
10
14
Yes
No
n = 24 
8 
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id sex age wt ht bmi anaesthesi comorb mp
1 1 27 65 171 22.2 1 0 2
2 1 56 59 159 23.3 1 0 2
3 1 53 70 168 24.8 2 1 1
4 1 24 47 160 18.4 1 0 2
5 1 29 84 179 26.2 1 0 2
6 1 46 69 169 24.2 1 0 2
7 1 60 60 164 22.3 1 0 1
8 1 18 50 171 17.1 1 0 1
9 1 43 80 174 26.4 1 0 2
10 1 26 72 174 24.1 1 0 1
11 1 53 69 159 30.2 1 0 3
12 2 59 67 145 31.9 2 1 3
13 1 31 66 168 23.4 1 0 1
14 1 42 75 173 25.1 1 0 2
15 1 42 70 164 26 1 0 2
16 1 18 62 173 20.7 1 0 2
17 1 45 64 153 27.3 2 1 2
18 1 27 71 166 25.8 1 0 2
19 2 41 77 145 36.6 2 2 2
20 1 35 58 179 18.1 1 0 1
21 1 37 54 155 22.5 1 0 1
22 2 31 75 163 28.2 1 0 2
23 1 26 65 171 22.2 1 0 1
24 2 31 39 146 18.3 1 0 1
25 1 41 55 170 19 2 1 2
26 2 65 55 150 24.4 2 1,2,4 3
27 1 57 54 165 19.8 2 1 2
28 1 28 56 163 21.1 1 0 2
29 1 55 56 165 20.6 2 2 2
30 2 60 42 145 20 1 0 2
31 2 18 45 147 20.8 1 0 1
32 1 29 72 165 26.4 1 0 2
33 1 51 84 164 31.2 2 1,2 3
34 1 46 83 180 25.6 1 0 2
35 2 48 84 157 34.1 2 1,2 3
36 2 48 61 155 25.4 1 0 1
37 2 48 85 165 31.2 1 0 2
38 1 22 65 170 22.5 1 0 1
39 1 43 59 165 21.7 1 0 1
40 2 28 68 150 30.2 1 0 2
41 2 49 72 160 28.1 2 1 2
42 1 57 45 175 14.7 1 0 1
43 1 32 62 170 21.5 1 0 2
44 1 30 90 175 29.8 1 0 3
45 1 39 74 169 25.9 1 0 2
46 1 31 64 156 26.3 1 0 3
47 1 44 70 167 25.1 1 0 3
48 1 58 60 165 22 1 0 3
49 1 30 45 162 17.1 2 1
50 2 55 54 158 21.6 1 0 1
51 1 25 65 165 23.5 1 0 2
52 1 31 65 170 22.5 1 0 2
53 1 58 66 162 25.1 1 0 2
54 2 51 65 155 27.1 1 0 2
55 2 48 66 155 27.5 2 1 1
56 1 39 70 170 24.2 1 0 1
57 1 28 51 164 19 1 0 1
58 1 31 65 177 20.7 2 4 2
59 1 21 50 163 18.8 1 0 1
60 2 34 50 153 21.4 1 0 2
61 2 40 65 169 22.8 1 0 1
62 2 41 71 149 32 2 2,4 2
63 1 21 65 172 22 1 0 2
64 2 38 45 143 22 1 0 1
65 2 39 57 156 23.4 1 0 2
66 2 50 60 154 25.3 2 1 2
67 2 18 56 163 21.1 1 0 1
68 1 31 70 180 21.6 1 0 2
69 1 23 55 174 18.2 1 0 1
70 2 41 74 162 28.2 1 0 1
71 1 64 63 170 21.8 1 0 2
72 1 65 85 165 31.5 2 1,2 3
73 1 42 80 175 26.1 1 0 2
74 1 22 48 176 15.5 1 0 1
75 1 56 85 170 29.4 1 0 2
76 2 65 65 159 25.7 2 1 2
77 1 43 53 159 21 1 0 2
78 2 61 65 158 26 2 1 3
79 2 51 60 147 27.8 2 1 2
80 2 35 44 152 19 1 0 1
81 2 21 56 146 26.3 1 0 1
82 2 42 63 146 28.4 1 0 1
83 2 39 57 150 25.3 1 0 1
84 1 62 80 164 29.7 1 0 2
85 2 55 51 167 18.5 1 0 1
86 1 35 74 166 27 1 0 3
87 1 38 65 163 24.5 1 0 2
88 1 36 96 175 31.3 2 6 3
89 1 58 67 173 22.4 1 0 3
90 1 42 70 175 22.9 2 2 1
91 2 32 74 153 31.6 1 0 2
92 1 49 59 163 22.2 2 1 3
93 1 23 62 183 18.5 1 0 2
94 1 48 70 167 25.1 1 0 3
95 2 49 54 151 23.7 1 0 2
96 1 47 102 185 29.8 1 0 2
97 1 38 57 164 21.2 1 0 3
98 1 63 56 163 21.1 2 1 2
99 1 51 72 162 27.4 1 0 3
100 2 37 63 150 28 1 0 3
101 1 29 76 171 26 1 0 3
102 1 56 74 165 27.2 1 0 2
103 1 38 64 157 26 1 0 2
104 1 44 77 169 27 2 1 1
105 1 32 73 148 33.3 1 0 2
106 1 27 51 160 19.9 1 0 2
107 2 25 54 154 22.8 1 0 1
108 2 57 67 158 26.8 1 0 2
109 1 65 76 158 30.42 1 1 1
110 2 51 62 156 25.5 1 0 3
111 2 34 64 152 27.7 1 0 2
112 2 40 64 153 27.3 1 0 1
113 2 36 36 153 15.4 1 0 2
114 1 32 59 162 22.5 1 0 1
115 2 45 55 149 25.2 2 2 2
116 1 28 53 170 18.3 1 0 2
117 2 21 47 150 20.9 1 0 1
118 1 35 85 159 33.6 1 0 3
119 1 38 85 169 29.8 1 0 2
120 2 43 57 149 25.7 1 0 2
121 1 27 79 173 26.4 1 0 1
122 1 32 66 167 23.7 1 0 1
123 1 27 69 163 26 1 0 2
124 1 33 66 172 22.3 1 0 1
125 1 45 75 154 31.6 1 0 3
126 1 46 75 167 27.5 1 0 2
127 1 40 80 170 27.7 1 0 1
128 1 29 45 170 15.6 1 0 1
129 2 49 55 136 29.7 1 0 1
130 2 26 55 159 21.8 1 0 2
131 1 23 69 171 23.6 1 0 1
132 1 36 70 159 29.6 1 0 2
133 1 55 60 165 22 1 0 3
134 2 62 52 148 23.7 2 2 2
135 1 35 63 175 20.6 1 0 3
136 1 39 75 166 27.2 1 0 1
137 1 55 65 160 25.4 2 2 1
138 1 20 56 175 18.3 1 0 3
139 1 43 54 165 19.8 2 3 1
140 2 23 50 153 21.4 1 0 1
141 1 53 87 178 27.5 1 0 3
142 1 34 78 1 0 2
143 1 30 80 175 26.1 1 0 1
144 1 36 49 170 17 1 0 4
145 1 31 60 168 21.3 1 0 2
146 1 48 78 170 27 1 0 3
147 1 36 80 169 28 1 0 3
148 1 65 57 157 23.1 2 1 3
149 1 39 95 174 31.3 2 2 3
150 2 25 79 162 30.1 1 0 1
151 1 39 82 176 26.5 2 1 1
152 1 50 60 165 22 2 3 1
153 1 38 55 165 20.2 1 0 1
154 2 27 54 159 21.4 1 0 2
155 2 23 50 150 22.2 1 0 1
156 2 39 50 149 27.5 1 0 1
157 2 61 60 150 26.7 2 1 3
158 1 59 72 165 26.4 1 0 1
159 2 56 70 155 29.1 2 1,2 2
160 2 31 67 165 24.6 1 0 3
161 1 48 60 161 23.1 1 0 3
162 1 37 75 165 27.5 1 0 3
163 1 51 78 172 26.4 1 0 3
164 1 53 67 159 26.5 2 2 3
165 1 31 60 163 22.6 1 0 1
166 1 55 60 167 21.5 1 0 3
167 1 59 89 176 28.7 2 4 2
168 1 42 65 157 26.4 1 0 3
169 1 42 52 147 24.1 1 0 2
170 1 20 70 178 22 1 0 2
171 2 50 63 151 27.63 2 2 2
172 1 32 82 177 26.19 2 7 1
173 1 41 72 178 22.72 1 0 2
174 2 31 62 160 24.21 2 2 2
175 1 27 55 177 17.6 1 0 2
176 2 23 55 162 20.9 1 0 2
177 2 35 55 151 24.1 1 0 3
178 2 40 50 155 20.8 1 0 2
179 1 44 70 169 24.5 1 0 2
180 2 48 84 158 33.6 2 2,4 3
181 1 21 85 175 27.8 1 0 1
182 2 55 73 159 28.9 1 0 3
183 2 25 63 149 28.4 1 0 1
184 1 26 71 167 25.5 1 0 3
185 2 39 60 152 26 1 0 2
186 2 29 63 164 23.4 1 0 1
187 1 45 68 170 23.5 1 0 1
188 1 34 70 170 24.2 1 0 1
189 1 33 65 165 23.9 1 0 2
190 2 41 35 169 13.7 1 0 1
191 2 28 50 148 22.8 1 0 2
192 1 26 64 170 22.1 1 0 1
193 1 19 57 179 17.8 1 0 1
194 1 48 59 165 21.7 1 0 1
195 1 64 72 163 27.09 1 0 2
196 1 27 69 172 23.3 1 0 1
197 1 50 45 160 17.5 1 0 3
198 1 56 61 172 20.61 2 2 3
199 1 42 57 165 20.93 1 0 3
200 1 27 78 181 23.8 1 0 3
201 1 28 62 174 20.47 1 0 1
202 1 31 70 172 23.7 1 0 2
203 2 24 63 160 24.6 1 0 2
204 1 30 62 148 28.3 1 0 2
205 1 18 65 168 23 1 0 1
206 1 22 55 155 22.9 1 0 1
207 1 51 52 165 19.1 1 0 1
208 1 20 45 169 15.8 1 0 1
209 1 35 72 175 23.5 1 0 2
210 1 56 66 166 24 1 0 3
211 2 41 60 155 25.2 1 0 2
212 1 52 75 158 30 2 2 3
213 1 59 65 165 23.9 1 0 2
214 1 57 68 165 25 1 0 2
215 2 44 61 157 24.7 1 0 2
216 1 19 43 162 16.4 1 0 2
217 1 36 53 165 19.5 1 0 2
218 1 18 50 173 16.7 1 0 1
219 2 40 75 160 27.5 1 0 2
220 2 25 78 158 31.2 2 1 1
221 1 41 74 173 24.7 2 1,2 3
222 1 45 56 164 20.8 1 0 2
223 1 40 80 180 24.7 1 0 2
224 1 40 80 174 26.4 1 0 3
225 1 47 50 160 19.5 1 0 2
226 1 47 80 170 27.7 1 0 3
227 2 32 52 159 20.6 1 0 2
228 1 32 82 168 29.1 2 2 3
229 1 42 64 164 23.8 1 0 1
230 1 52 80 172 27 2 1 1
231 1 46 68 168 24.1 1 0 2
232 2 44 36 138 18.9 1 0 2
233 2 43 55 148 25.1 1 0 1
234 2 40 56 156 23 1 0 2
235 2 50 50 146 23.5 2 1 2
236 1 24 50 165 18.4 1 0 2
237 1 27 56 157 22.7 1 0 2
238 1 40 55 156 22.2 1 0 1
239 1 64 93 173 31.1 2 2 3
240 1 30 60 167 21.9 1 0 2
241 1 54 50 153 21.4 1 0 2
242 1 19 65 1 0 1
243 1 26 68 173 22.7 1 0 1
244 2 22 75 165 27.5 1 0 1
245 1 55 76 1 0 3
246 1 28 59 1 0 1
247 1 25 104 177 33.2 1 0 1
248 1 37 64 167 22.9 1 0 1
249 1 30 53 1 0 2
250 1 18 50 1 0 1
251 1 36 60 160 23.4 1 0 2
252 2 33 56 1 0 3
253 1 61 67 170 23.2 2 1,2,5 1
254 2 65 50 1 0 3
255 2 64 50 1 0 1
256 1 48 70 1 0 1
257 1 31 93 1 0 3
258 1 43 78 2 2 3
259 1 48 86 1 0 1
260 1 33 82 1 0 2
261 1 32 65 165 23.9 1 0 2
262 1 24 67 162 25.5 1 0 3
263 2 39 53 160 20.7 1 0 2
264 2 28 36 139 18.6 1 0 1
265 1 40 54 2 3 1
266 2 36 60 158 24 1 0 2
267 1 43 77 168 27.3 2 2 3
268 1 52 50 163 19.2 1 0 3
269 2 26 65 1 0 3
270 1 39 63 167 22.6 1 0 3
271 1 50 70 1 0 2
272 1 49 64 164 23.8 1 0 2
273 1 33 75 1 0 2
274 2 62 63 149 28.4 1 0 2
275 2 27 67 156 27.5 1 0 1
276 2 27 60 1 0 1
277 1 50 75 1 0 3
278 1 24 59 175 19.3 1 0 1
279 1 44 85 170 29.4 1 0 2
280 1 49 62 2 2 2
281 2 32 55 152 23.8 1 0 1
282 1 26 60 1 0 2
283 1 32 67 1 0 1
287
1
teeth neck surgery jr gc ptmove ls oinc tina
1 1 EUA + cystoscopy 1 2 3 1 2 1
1 1 partial penectomy 1 1 1 1 1 1
5 1 EIU 2 2 1 1 2 1
1 1 rt orchidectomy 3 2 2 1 4 2
1 1 meatoplasty + EIU 2 2 3 1 3 1
1 1 implant exit r prox tibia2 1 2 1 2 1
2 1 rt inguinal hernioplasty1 1 1 1 1 1
1 1 lt inguinal hernioplasty1 1 1 1 1 1
1 1 lt hydrocoel 1 1 1 1 1 1
1 1 EUA, LOF + seton exit1 1 1 1 1 1
1 1 EUA LOF 2 1 1 1 1 1
1 2 lipoma excision 1 1 1 1 1 1
1 1 1 1 1 1 1 1
2,4 1 implant exit shoulder2 1 1 1 1 1
1 2 excision lipoma,vasectomy1 1 1 1 1 1
1 1 circumcision, inguinal hernioplasty2 1 3 1 4 2
1 1 haemorroidectomy 1 1 1 1 1 1
1 1 excision lipoma back1 1 1 1 1 1
1 1 EUA LOF 2 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 knee arthroscopy meniscal repair1 1 1 1 1 1
1 1 hip biopsy 1 1 2 1 2 1
1 1 suture removal and casting3 1 3 1 4 2
1 1 STSG 1 1 1 1 1 1
1 2 lt great toe ray amputation2 1 1 1 2 1
2 2 RT BK STUMP REVISION2 1 1 1 1 1
1 1 1 1 1 1 1 1
1 1 OPEN BX KNEE 1 1 1 1 2 1
2 1 BX KNEE 1 1 1 1 1 1
1 1 1 3 3 1 3 1
1 1 BONE STAPLE REMOVAL2 1 1 1 2 1
1 3 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 RT MRM 2 1 1 1 1 1
1 1 EXCISION FIBROADENOMA LT BREAST1 1 1 1 1 1
1 1 SYNOVIAL BIOPSY LT WRIST1 1 1 1 1 1
1 1 K WIRE EXIT 2 3 4 1 4 3
1 1 tympanoplasty 1 1 1 1 1 1
3 1 excision granuloma lt finger1 1 1 1 1 1
1 2 OCTR 1 1 1 1 1 1
1 1 HAEMARROIDS 1 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 2 1 1 1 1 1
1 1 EUA LOF 2 1 4 1 3 1
1 1 EUA LOF 2 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 2 1 1 1 1 1
1 1 BIOPSY ANKLE SYNOVIUM1 1 1 1 1 1
1 1 RT KNEE SCREW REMOVAL1 1 1 1 1 1
1 1 STSG LEG 1 1 1 1 1 1
1 1 MRM RT 1 1 1 1 1 1
1 1 LT MRM 1 1 1 1 1 1
1 1 RT MRM 1 1 1 1 1 1
5 1 RESUTURING ANKLE 1 1 1 1 1 1
1 1 RT RADIUS AND TIBIA IMPLANT EXIT2 2 2 1 3 1
1 1 IMPLANT EXIT ANKLE3 3 4 1 3 1
1 1 LT KNEE OPEN SYNOVECTOMY1 1 1 1 1 1
1 1 EUA LOF 2 1 2 1 2 1
1 1 ANKLE SYNOVIAL AND BONE BX1 1 1 1 1 1
1 1 KNEE SCOPY 1 1 1 1 1 1
1 1 RT KNEE SCOPY 1 1 1 1 1 1
1 1 RT FIBROADENOMA EXCISION2 1 1 1 2 1
1 1 LT BREAST LUMP EXCISION1 1 1 1 1 1
1 1 RT MRM 2 1 1 1 1 1
1 1 GANGLION EXCISION1 1 1 1 1 1
1 1 WRIST BIOPSY 1 1 1 1 1 1
1 1 B/L RADIUS IMPLANT EXIT1 1 1 1 1 1
1 1 ANKLE BURSA EXCISION2 1 1 1 2 2
2 1 LT INGUINAL HERNIOPLASTY1 1 2 1 2 1
1 1 RT KNEE SCOPY 1 1 1 1 1 1
1 1 R KNEE SCOPY 1 1 1 1 1 1
1 1 RT INGUINAL HERNIOPLASTY2 1 2 1 2 1
1 1 EVERSION OF SAC 1 1 1 1 1 1
1 1 RT MRM 1 1 1 1 1 1
1 1 RT FIBULOTOMY+ BG2 1 1 1 2 2
1 1 lt radius k wire exit 1 1 1 1 1 1
1 1 RT HSD 1 1 1 1 1 1
1 1 LT BREAST LUMP WLE2 1 1 1 1 1
1 1 RT BREAST LUMP WLE1 1 1 1 1 1
1 1 WLE BREAST 1 1 1 1 1 1
1 1 BCS RT BREAST 1 1 2 1 2 1
2,5 2 EXCISION LIPOMA NECK2 1 1 1 2 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 2 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 2 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 1 1 1 1 1 1
1 1 BG RT TIBIA 2 1 1 1 2 1
1 1 IMPLANT EXIT LT HUMERUS2 2 3 1 4 2
1 1 EXCISION LIPOMA BACK2 1 1 1 1 1
1 1 HSD 1 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 2 1 1 1 1 1
1 1 LT INGUINAL HERNIPLASTY1 1 1 1 1 1
5 1 EUA LOF 2 1 1 1 1 1
1 1 EXCISION LIPOMA GLUTEAL REGION1 1 1 1 1 1
1 1 circumcision 1 1 1 1 1 1
2 1 ILIZAZOV RING ADJUSTMENT2 1 2 1 2 1
1 1 TSSA 2 1 2 1 3 2
1 1 TSSA 1 1 1 1 1 1
1 1 LT INGUINAL HERNIOPLASTY2 1 1 1 1 1
1 1 RT HERNIOPLASTY + CICUMCISION1 1 1 1 1 1
1 1 B/L LUMPECTOMY 2 1 1 1 1 1
1 1 RT KNEE SCOPY 1 1 1 1 1 1
1 1 RT INGUNAL HERNIOPLASTY1 1 1 1 1 1
1 1 WLE RT BREAST 1 1 1 1 1 1
1 1 RT TIBIA OPEN BX 1 1 1 1 1 1
1 1 WLE RT BREAST 2 2 3 1 3 1
1 1 WLE RT BREAST 1 1 1 1 1 1
1 1 WLE RT BREAST 1 1 1 1 1 1
1 1 MRM RT BREAST 2 1 1 1 1 1
1 1 TYMPANOPLASTY 2 1 1 1 1 1
1 1 RT WRIST GANGLION EXCISION2 2 3 1 3 1
1 1 K WIRE EXIT RT HAND2 1 1 1 1 1
1 1 K WIRE EXIT 2 1 1 1 1 1
2 1 GANGLON EXCISION RT HAND1 1 1 1 1 1
1 1 EUA LOF 2 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 2 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 3 1 1 1 4 2
1 1 STSG 3 1 2 1 4 2
1 1 ANT ABD WALL DEBRIDEMENT1 1 1 1 1 1
1 1 WLE RT BREAST 1 1 1 1 1 1
1 1 HAEMATOMA EXCISION1 1 1 1 1 1
1 1 EXCISION LIPOMA BACK1 1 1 1 1 1
1 1 LT INGUINAL HERNIOPLASTY1 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 2 1 1 1 1 1
1 1 EUA LOF 2 1 1 1 1 1
4 1 LT HYDROCOEL 1 1 1 1 1 1
1 1 IMPLANT EXIT LT ELBOW3 1 1 1 4 2
1 1 OLECRANON BURSA EXCISION1 1 1 1 1 1
1 1 CURETTAGE AND BG 2 1 3 1 2 1
1 1 RT TSSA 1 1 1 1 1 1
1 1 IMPLANT EXIT LT ANKLE1 1 2 1 2 1
1 1 B/L TSSA 2 1 1 1 1 1
1 1 BX RT ELBOW 1 1 1 1 1 1
1 1 STSG LT LEG 1 1 1 1 1 1
4 2 EUA LOF 1 1 1 1 1 1
1 1 UMBILICAL HERNIA REPAIR1 1 1 1 1 1
4 1 RT INGUINAL HERNIOPLASTY1 1 1 1 1 1
4 1 B/L HYDROCOELECTOMT2 1 2 1 2 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 LT KNEE SCOPY 1 1 1 1 1 1
1 1 1 1 1 1 1 1
1 1 RT FEMUR DEBRIDEMENT AND BG1 1 1 1 1 1
1 1 WLE B/L BREAST LUMP1 1 2 1 2 1
1 1 EXCISION RT BREAST LUMP1 1 1 1 1 1
1 1 WLE RT BREAST 1 1 1 1 1 1
4,5 1 RT MRM 1 1 1 1 1 1
1 1 LT HAND GANGLION EXCISION1 1 1 1 1 1
1 1 OCTR, 2 FINGERS TRIGGER FINGER RELEASE2 1 1 1 1 1
1 1 RT LUMPECTOMY 1 1 1 1 1 1
1 1 EPIGASTRIC HERNIA REPAIR1 1 1 1 1 1
1 1 SUBMENTAL NODE EXCISION1 1 1 1 1 1
1 1 LT INGUINAL HERNIA REPAIR3 1 1 1 4 2
4 1 EUA LOF 2 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
5 2 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 LT FEMUR NAIL EXIT 1 1 1 1 1 1
1 1 LT PROXIMAL TIBIA SCREW EXIT, BG1 1 2 1 2 1
3 1 EUA LOF 2 1 1 1 1 1
1 1 EUA LOF 2 1 2 1 1 1
1 1 EUA LOF 2 1 1 1 1 1
2 1 EUA LOF 1 1 2 1 2 1
1 1 LT KNEE SCOPY 1 1 1 1 1 1
1 1 LT LYMPH NODE BX 1 1 1 1 1 1
1 1 INCISIONAL HERNIA REPAIR1 1 1 1 1 1
1 1 STSG LT LL 2 1 2 1 2 1
1 1 LT FEMUR NAIL EXIT 1 1 1 1 1 1
1 1 HSD LT SHOULDER 1 1 1 1 1 1
1 1 LT ANKLE IMPLANT EXIT1 1 1 1 1 1
1 2 B/L RFA 1 1 1 1 1 1
1 1 RT FEMUR BX 2 1 1 1 1 1
1 1 TBW EXIT RT ELBOW1 1 1 1 1 1
1 1 RT BREAST HADFIELD'S SX2 1 1 1 1 1
1 1 INCISIONAL HERNIA REPAIR1 1 1 1 1 1
1 1 INCISIONAL HERNIA REPAIR2 1 1 1 1 1
1 1 LT KNEE SCOPY 1 1 1 1 1 1
1 1 LT TYMPANOPLASTY 2 1 1 1 1 1
1 1 RT BREAST WLE 2 1 1 1 1 1
1 1 RT TYMPANOPLASTY1 1 1 1 1 1
1 1 LT TYMPANOPLASTY 2 1 1 1 1 1
1 1 SCHWANOMMA EXCISION LT FINGER3 1 1 1 4 2
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 2 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 2 3 4 1 3 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 1 1 2 1 2 1
1 1 STSG LT LEG 1 1 1 1 1 1
1 1 RT FOOT CORN EXCISION1 1 1 1 1 1
1 1 BX RT THIGH 1 1 1 1 1 1
1 1 BX RT FEMUR 1 1 2 1 2 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 2 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 LAS 1 1 1 1 1 1
1 1 RT KNEE SCOPY 1 1 1 1 1 1
1 1 RT KNEE SCOPY 1 1 1 1 1 1
1 1 B/L HYDROCOELECTOMY2 2 2 1 2 1
1 1 LT FOREARM MASS BX1 1 1 1 1 1
1 1 RT KNEE OPEN BX 2 2 4 1 3 1
1 1 EUA LOF 2 1 1 1 1 1
1 1 LT HUMERUS OPEN BX1 1 1 1 1 1
1 1 LT HIP MASS BX 2 1 1 1 1 1
1 1 PARAUMBILICAL HERNIOPLASTY2 1 1 1 1 1
1 1 LT HYDROCOELECTOMY1 1 1 1 1 1
1 1 RT INGUINAL HERNIOPLASTY2 2 3 1 4 2
1 1 EUA LOF 2 1 3 1 2 2
1 1 EUA LOF 2 1 3 1 3 2
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
2 1 K WIRE EXIT, DEBRIDEMENT, BG1 1 1 1 1 1
1 1 RT HIP BX 1 1 1 1 1 1
1 1 RT KNEE SCOPY 2 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 RT MRM 2 1 2 1 2 1
1 1 LT MRM 2 1 2 1 2 1
1 1 RT MRM 1 1 1 1 1 1
1 1 WLE BREAST 1 1 1 1 1 1
1 1 OPEN BX RT HIP 2 1 1 1 1 1
1 1 DEBRIDEMENT SEQUESTRECTOMY1 1 1 1 1 1
3 1 LT TSSA 1 1 1 1 1 1
1 3 RT RFA 3 1 1 1 4 2
1 1 B/L TSSA 1 1 1 1 1 1
1 1 INCISIONAL HERNIA REPAIR2 1 1 1 1 2
1 1 LT FEMUR DEBRIDEMENT SEQUESTRECTOMY1 1 1 1 1 1
1 1 1 1 1 1 1 1
1 1 RT ANKLE SYNOVIAL BX1 1 1 1 1 1
1 2 CYSTOLTHLAPEXY 2 1 1 1 1 1
1 1 MEATOPLASTY 1 1 1 1 1 1
1 1 CIRCUMCISION 1 1 1 1 1 1
1 1 RT HYDRCOELECTOMY1 1 1 1 1 1
1 1 EIU 1 1 1 1 1 1
1 1 THYROGLOSSAL CYST EXCISON1 1 1 1 1 1
1 1 STOMA CLOSURE 1 1 1 1 1 1
1 1 SKIN TAG EXCISION 2 1 3 1 3 1
1 1 DJ STENT REMOVAL 1 1 1 1 1 1
5 2 RT SUBMANDIBULAR GLD EXCISION1 1 1 1 1 1
1 1 IND KNEE 1 1 1 1 1 1
1 1 LT INGUINAL HERNIOPLASTY2 3 3 1 3 1
1 1 IM NAIL REMOVAL 2 1 1 1 1 1
1 2 HYDROCOEL REPAIR 1 1 1 1 1 1
1 1 EXCISION LPOMA NECK1 1 1 1 1 1
1 1 ARTHROSCOPY KNEE1 1 1 1 1 1
1 1 ILIAC BONE BX 2 4 3 2 4 2
1 1 LIPOMA EXCISION FOREHEAD1 1 1 1 1 1
1 1 ACL LT KNEE 1 1 1 1 1 1
1 1 TBW LT WRIST 1 1 3 1 3 1
1 1 PUV FULGURATION 1 1 1 1 1 1
1 1 AXILLARY LN EXCISION1 1 1 1 1 1
1 1 EUA LOF 1 1 2 1 2 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 B/L TSSA 2 1 1 1 2 1
1 1 RT INGUINAL HERNIOPLASTY2 1 1 1 2 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 CYSTOLITHLAPEXY 1 1 1 1 1 1
1 1 IM NAIL EXIT TIBIA 1 1 1 1 1 1
1 1 INCISIONAL HERNIA REPAIR1 1 1 2 2 1
1 1 RT BREAST LUMP EXCISION2 1 1 1 1 1
1 1 ANKLE SCREW EXIT 1 1 1 1 1 1
1 1 EUA LOF 1 1 1 1 1 1
1 1 DIAGNOSTIC ARTHROSCOPY KNEE1 1 1 1 1 1
1 1 TYMPANOPLASTY 1 1 1 1 1 1
1 1 CYSTSCOPY, EUA, CIRCUMCISION2 1 1 1 1 1
1 1 INTRA TYMPANIC STEROID INJECTION1 1 4 1 3 1
1 1 REDO CORTICOTMY 2 1 2 1 2 1
1 1 EIU 1 1 1 1 1 1
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1
tpropr tpropr1 hrpreind sbppreind dbppreind mappreimdspo2prein hrpostind sbppostin
165 2 87 131 84 95 100 82 89
120 1 91 90 50 60 100 72 94
140 1 56 114 72 81 100 60 106
150 2 111 145 86 99 100 100 95
240 2 115 146 85 99 100 91 104
140 1 75 117 71 83 99 71 103
120 1 82 96 100 69
100 1 91 116 59 72 100 83 120
160 1 76 86 97 70
140 1 91 108 58 70 100 75 110
140 1 76 148 103 113 98 74 102
135 1 74 137 98 105 98 82 101
130 1 71 95 54 63 99 65 93
160 1 70 127 66 79 100 66 91
140 1 85 142 81 96 99 85 107
180 2 83 116 71 81 100 86 102
130 1 62 128 82 93 99 69 92
140 1 99 148 102 112 98 86 102
160 1 93 97 67 74 100 85 101
120 1 68 127 79 90 96 60 86
110 1 106 135 82 94 100 86 121
150 1 67 136 81 93 100 67 130
130 1
120 2 142 122 76 88 100 100 94
110 1 102 132 81 91 99 99 113
110 1 168 78 101 97 102 157
110 1 106 125 72 86 95 109 120
110 1 94 131 77 89 100 96 110
110 1 70 181 88 113 100 47 120
85 1 81 120 58 73 100 70 101
135 2 111 132 80 91 100 97 98
150 1 82 154 110 120 100 82 101
170 1 86 148 80 92 99 77 112
165 1 63 102 58 68 100 64 128
170 1 89 137 70 86 96 86 130
120 1 99 112 63 75 100 79 79
170 1 90 160 63 80 100 88 90
190 2 84 133 91 99 100 76 100
120 1 64 132 84 97 100 67 96
140 1 68 101 52 63 98 71 106
150 1 84 172 87 104 98 71 118
90 1 77 147 58 79 100 68 81
125 1 73 112 54 73 100 65 97
180 1 85 119 79 87 100 77 95
150 1 80 121 76 86 100 78 88
190 2 105 112 71 81 100 100 107
140 1 76 106 72 82 100 68 118
120 1 86 153 70 90 100 64 84
90 1 103 100 60 73 100 92 85
110 1 89 132 85 95 99 82 87
130 1 68 131 73 86 100 78 108
130 1 97 112 100 103 99 96 99
130 1 64 162 76 96 100 58 114
130 1 97 109 56 67 99 90 118
130 1 94 181 75 96 97 77 110
140 1 80 143 88 101 99 77 118
150 2 83 129 71 85 99 80 93
195 2 106 139 93 103 100 107 138
100 1 83 126 70 86 100 79 104
100 1 72 113 65 77 99 69 91
130 1 86 121 77 88 99 84 101
140 1 117 103 61 71 100 75 109
130 1 72 148 69 86 100 68 94
90 1 84 138 85 99 100 84 99
115 1 79 149 93 106 100 74 109
120 1 70 135 76 89 98 70 128
110 1 102 121 63 77 100 102 99
140 1 84 134 92 102 100 72 98
110 1 66 141 60 77 100 66 139
150 1 70 138 75 90 99 61 92
120 1 59 137 78 93 100 57 121
170 1 78 153 66 85 100 77 106
160 1 90 173 56 81 100 76 107
100 1 64 109 68 78 100 61 94
170 1 70 136 92 102 100 66 82
130 1 93 149 71 90 100 79 100
160 1 60 133 77 90 99 61 93
130 1 66 176 82 105 99 69 125
120 1 99 181 78 103 97 72 123
90 1 79 108 72 80 100 72 96
120 1 116 126 46 65 100 96 92
125 1 95 144 67 86 98 91 117
115 1 104 141 68 85 100 85 119
160 1 90 162 91 109 100 80 95
110 1 100 136 81 93 100 79 107
150 1 92 132 78 90 100 68 102
130 1 88 119 79 89 100 88 118
200 1 64 133 78 91 100 63 103
135 1 88 121 75 87 100 72 118
140 1 82 137 88 99 100 82 92
140 1 90 121 75 87 99 82 118
120 1 96 134 84 96 99 91 102
186 2 64 152 64 84 100 71 93
140 1 95 180 84 108 99 54 97
140 1 90 105 100 78
200 1 68 128 84 93 99 69 94
120 1 89 158 83 101 100 71 107
120 1 81 140 105 111 99 73 84
140 1 70 121 76 88 100 71 98
130 1 91 120 78 88 100 87 97
140 1 77 133 81 98 98 66 104
222 2 73 117 75 84 96 76 128
200 2 114 135 94 103 99 95 105
155 1 81 122 88 97 100 84 108
150 1 84 144 78 94 98 80 101
110 1 119 129 76 85 100 94 114
110 1 100 112 95 100 100 80 97
135 1 80 180 95 115 99 74 105
150 1 66 148 79 96 96 60 102
125 1 87 152 86 101 99 88 103
130 1 86 101 59 68 100 78 83
190 2 133 160 86 103 100 90 106
75 1 105 160 89 106 98 92 130
120 1 66 114 71 81 100 69 91
110 1 80 147 103 114 95 74 101
100 1 80 101 68 75 100 72 90
150 2 105 116 70 80 100 108 90
170 1 86 129 74 88 96 75 96
170 1 80 133 93 100 100 69 109
115 1 103 136 85 98 97 78 92
160 1 62 115 68 77 100 62 97
130 1 76 119 68 81 100 66 98
140 1 85 121 82 91 100 85 100
130 1 67 106 76 83 100 60 90
150 1 94 157 84 100 100 84 126
150 1 83 121 76 87 99 70 76
240 2 83 145 75 93 100 78 129
140 2 80 89 41 51 100 82 98
110 1 90 163 80 100 100 78 124
110 1 80 109 67 77 99 79 95
140 1 72 135 89 97 100 77 113
140 1
120 1 67 147 81 96 99 52 82
110 1 94 156 88 104 100 80 76
120 1 77 137 97 106 99 94 141
150 1 70 123 76 87 99 70 95
130 1 91 146 84 96 100 77 103
170 2 60 147 63 87 100 58 98
110 1 64 116 71 82 100 60 71
150 2 86 124 81 91 100 90 89
175 1 78 124 73 86 99 73 91
160 1 91 143 97 106 100 92 115
160 1 66 120 69 81 99 63 96
100 1 97 119 80 89 100 94 98
120 1 94 130 75 87 100 94 111
160 1 64 129 79 89 100 55 84
160 1 99 120 66 80 98 87 98
115 1 90 146 29 59 98 71 96
190 1 107 168 89 99 99 91 121
160 1 94 106 45 60 99 80 93
165 1 79 161 90 106 100 76 117
120 1 85 118 82 90 98 83 115
110 1 94 131 87 96 100 92 105
110 1 90 116 68 79 100 80 97
100 1 94 115 68 79 99 78 87
120 1 81 144 79 95 100 68 90
120 1 94 154 70 98 100 80 119
145 1 77 139 85 98 98 80 63
140 1 70 123 96 103 100 67 120
135 1 70 120 70 90 100 69 93
120 1 80 152 89 103 100 79 129
135 1 100 137 85 96 100 86 99
230 2 104 110 72 81 100 93 100
135 1 82 150 98 111 100 76 125
120 1 70 116 81 88 100 70 96
120 1 64 156 94 106 100 60 109
180 1 70 149 88 103 100 78 117
120 1 96 103 66 74 99 86 111
100 1 85 101 57 67 100 69 116
220 2 107 151 84 99 100 84 118
120 1 87 150 84 95 99 65 94
160 1 84 130 76 89 100 79 124
140 1 101 166 94 111 98 73 107
130 1 124 124 84 94 99 120 125
110 1 68 136 81 92 100 52 123
110 1 96 128 58 73 100 89 87
110 1 81 140 78 93 100 60 94
100 1 113 132 91 99 100 110 127
140 1 77 132 54 72 100 72 101
170 1 102 145 73 88 100 80 118
170 1 70 126 77 89 100 69 122
140 1 88 130 74 88 100 84 100
130 1 76 118 62 76 100 70 127
140 1 82 120 57 74 100 78 101
120 1 90 126 84 79 100 86 126
120 1 85 106 74 81 100 69 85
140 1 102 135 77 90 100 108 109
140 1 96 118 73 82 97 77 90
130 1 101 146 71 86 100 77 114
70 1 77 110 65 76 100 77 87
100 1 91 133 76 89 100 59 89
130 1 101 138 76 92 99 70 108
180 2 66 117 72 84 100 66 90
120 1 79 116 75 84 100 81 104
140 1 65 102 61 69 100 67 99
140 1 84 132 76 89 99 70 92
100 1 90 124 86 96 98 78 84
120 1 79 132 78 90 98 70 116
180 2 81 122 77 88 100 89 135
160 1 68 118 68 78 100 68 127
135 1 99 136 82 94 99 72 138
140 1 81 147 59 80 99 81 83
120 1 104 121 84 93 100 89 106
125 1 93 121 82 89 100 77 117
130 1 109 155 76 94 100 98 131
110 1 88 134 75 89 100 92 125
110 1 79 139 85 98 100 70 134
90 1 58 111 68 78 100 58 89
150 1 73 125 82 92 100 78 100
120 1 77 127 73 84 100 77 101
120 1 77 129 67 82 99 85 93
150 1 53 144 78 94 100 43 97
130 1 75 100 55 107
125 2 120 151 97 110 100 113 125
120 1 75 134 82 95 100 76 77
130 2 87 129 69 83 100 78 87
110 1 68 118 70 81 100 69 96
100 1 94 120 65 76 100 74 89
150 1 96 134 86 96 100 78 93
155 1 85 115 84 91 100 85 90
150 1 95 135 85 102 100 90 85
160 2 81 128 75 89 100 74 118
220 2 87 138 74 88 100 90 139
220 2 82 145 84 98 99 93 107
100 1 80 113 76 84 100 71 112
160 1 75 135 79 93 100 78 95
100 1 82 145 84 98 99 93 107
160 1 74 157 88 104 100 64 150
130 1 80 141 108 115 100 88 130
160 1 73 144 83 97 100 63 108
140 1 60 120 77 87 98 55 100
70 1 109 108 70 79 100 107 98
110 1 96 88 55 63 96 91 91
115 1 68 86 49 57 100 60 83
100 1 81 120 72 86 100 73 91
100 1 125 109 54 65 100 130 118
110 1 93 141 73 89 100 99 101
100 1 65 117 74 85 96 73 92
180 1 77 132 76 90 93 71 91
120 1 101 126 87 96 100 77 104
100 1 83 99 57 67 98 78 95
120 1 93 137 76 90 99 79 108
140 1 89 109 67 76 98 88 96
150 1 124 133 57 73 100 98 92
150 1 61 150 65 88 100 47 117
120 1 98 146 77 93 100 90 110
200 1 85 111 52 65 100 79 106
130 1 81 135 93 102 100 71 96
110 1 95 124 82 92 100 86 101
100 1 100 136 63 80 100 85 97
120 1 110 112 64 76 96 102 97
150 2 80 130 78 95 100 78 120
150 1 67 184 85 108 98 63 146
100 1 80 140 90 100 97 78 100
100 1 92 130 106 111 100 92 79
210 2 130 135 52 71 100 89 94
190 1 85 188 94 110 100 73 108
150 1 96 126 73 85 100 69 108
170 1 82 136 91 102 98 83 95
165 1 99 134 90 100 100 89 98
190 2 120 136 87 97 100 113 115
140 1 106 133 73 87 100 101 114
100 1 64 118 62 73 100 64 94
105 2 96 139 88 100 100 64 94
110 1 76 147 92 104 100 61 98
120 1 65 122 62 76 100 64 125
150 1 81 146 90 102 100 78 93
100 1 45 127 64 80 100 41 80
130 1 82 125 77 89 100 87 125
150 1 68 120 80 93 100 61 86
150 1 92 148 80 98 100 94 156
120 1 62 117 69 81 98 69 84
150 1 85 140 90 115 100 65 102
190 2 51 182 86 111 100 54 98
135 1 89 131 82 91 100 74 112
120 1 84 123 79 89 100 79 86
150 1 68 125 85 95 98 69 87
120 1 71 114 70 81 100 71 110
170 1 86 147 104 112 99 86 130
120 1 66 114 76 86 100 61 112
150 2 82 106 82 88 100 84 113
120 1 103 130 78 90 100 94 124
135 1 100 148 95 108 97 98 113
283
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1
dbppostin mappostin spo2posti hrpostins sbppostin1 dbppostin1mappostin1spo2posti1 vaso
43 54 100 59 91 48 58 100 2
53 60 100 70 83 47 55 100 2
63 73 100 60 88 59 65 100 1
62 69 100 79 101 55 66 100 2
62 73 100 73 99 54 64 100 2
63 72 100 72 103 64 72 100 2
78 100 60 62 100 1
55 70 100 74 89 44 54 100 1
64 100 83 91 100 2
62 74 100 56 99 54 65 100 2
68 76 100 67 111 71 80 100 2
60 69 100 72 68 47 52 99 1
48 59 100 56 89 49 58 100 2
59 67 100 63 95 49 60 100 1
84 90 100 75 97 55 66 100 2
55 66 100 74 84 42 52 100 1
59 67 100 67 83 49 58 100 2
71 78 100 75 94 46 56 100 2
82 85 100 78 88 46 55 100 2
51 60 100 51 80 48 56 100 2
68 81 100 78 103 53 65 100 2
79 92 100 63 105 55 67 100 2
2
55 64 100 96 84 45 54 100 2
79 88 99 104 136 94 104 99 2
77 95 98 80 125 67 81 100 2
65 79 100 109 70 52 56 100 1
57 69 100 85 100 44 58 100 2
68 85 100 44 116 61 76 100 2
58 64 100 59 78 43 51 100 1
61 70 100 97 103 55 66 100 2
88 91 100 76 127 82 93 96 2
66 78 100 72 134 82 95 100 2
69 83 100 68 126 76 87 100 2
70 85 99 82 113 86 91 98 2
42 51 100 74 109 58 70 100 1
60 70 99 80 90 60 70 100 2
41 55 100 80 109 53 66 100 1
66 72 100 66 89 63 70 100 2
44 58 99 62 97 48 59 99 2
58 78 100 69 109 56 67 100 2
43 50 100 58 72 45 51 100 1
52 67 100 67 90 48 62 100 2
50 61 100 79 99 49 60 100 2
70 76 100 73 94 58 70 100 2
66 75 100 85 101 61 71 100 2
60 73 99 69 108 69 78 95 2
48 57 100 61 83 56 62 100 2
43 53 100 85 91 44 55 100 2
56 63 100 83 100 62 72 100 2
47 60 100 74 102 64 71 100 2
50 62 100 96 106 54 66 100 2
56 71 100 58 90 46 60 100 2
63 73 100 68 143 66 78 100 2
44 55 99 68 106 43 52 100 2
68 80 100 72 105 63 73 100 2
55 63 99 76 102 56 67 100 2
89 100 100 88 141 97 107 100 2
42 57 100 79 90 45 56 100 2
50 60 100 55 91 49 58 100 2
52 63 100 72 105 66 75 100 2
74 82 100 87 122 71 84 100 2
44 55 100 57 90 44 55 100 2
55 65 100 69 82 52 59 100 2
78 86 100 72 100 73 80 100 2
82 93 99 70 80 50 57 99 2
47 59 100 81 95 45 57 100 2
60 69 100 58 98 55 64 100 2
70 81 100 73 91 35 47 100 1
51 61 100 62 93 55 63 100 2
73 85 100 59 111 67 78 100 2
65 75 100 74 104 65 75 100 2
44 55 100 75 114 51 65 100 2
54 63 100 64 95 56 65 100 2
55 61 100 64 92 61 68 100 2
60 73 100 78 79 41 50 100 2
65 72 100 63 84 56 62 100 2
77 89 99 80 90 51 59 97 2
90 98 99 82 100 85 88 95 2
58 67 100 68 91 52 62 100 2
51 60 100 96 89 55 63 100 2
59 76 100 87 102 51 62 100 2
63 73 100 74 95 41 54 100 2
64 71 100 79 76 60 63 99 2
62 73 100 72 91 56 64 100 2
55 66 100 72 99 59 68 99 2
71 82 100 74 109 62 73 99 2
59 68 100 71 94 49 59 99 2
73 84 100 69 100 62 72 100 2
51 61 100 69 95 57 65 100 2
73 84 92 81 85 51 57 99 2
66 74 99 87 105 73 80 100 2
48 59 100 68 103 51 63 100 2
56 64 100 48 92 50 60 100 2
97 100 68 103 100 2
68 75 99 77 102 66 73 97 2
48 61 100 60 106 58 67 100 2
62 66 100 62 74 52 58 100 2
38 53 100 71 95 57 65 100 2
53 64 100 80 99 57 65 100 2
54 66 100 57 83 47 56 100 2
87 97 100 84 117 83 91 97 2
70 77 100 96 107 64 75 100 2
73 82 100 82 116 76 86 98 2
49 61 98 68 101 58 69 100 2
85 92 100 73 84 45 53 100 2
51 61 100 78 93 45 56 100 2
57 69 100 70 93 47 58 100 2
47 54 100 55 89 46 55 96 1
69 76 99 81 103 61 70 99 2
47 55 100 78 92 41 53 100 2
51 64 100 91 98 54 64 100 2
69 84 100 66 96 56 66 100 2
55 63 100 74 102 63 72 100 2
69 77 100 68 91 65 72 100 2
54 62 100 72 91 54 62 100 2
51 61 100 92 92 50 60 100 2
61 70 98 78 104 65 72 96 2
66 76 100 74 129 78 90 100 2
55 64 100 76 102 64 73 100 2
48 60 100 55 98 51 63 100 2
50 62 100 65 115 70 80 100 2
52 63 100 77 108 64 75 100 2
52 61 100 58 97 63 71 100 2
97 105 100 94 107 57 69 100 2
38 47 100 67 93 53 63 100 1
78 87 100 78 107 65 76 100 2
53 64 100 76 99 73 79 100 2
47 68 100 70 92 53 62 100 2
50 61 100 58 95 45 56 100 2
63 75 100 62 108 58 70 100 2
245 54 100 53 88 53 60 100 2
48 54 100 75 85 51 59 100 2
100 110 99 79 104 61 72 100 2
61 69 99 65 101 64 72 100 2
64 73 100 63 102 65 73 100 2
51 61 100 53 95 45 57 100 2
53 58 100 55 79 50 57 100 2
49 60 100 83 95 46 58 100 2
58 65 99 68 103 66 75 100 2
63 76 100 83 112 63 75 100 2
52 62 100 59 94 58 66 100 2
67 74 100 90 95 56 65 100 2
62 74 100 93 117 64 78 100 2
45 55 100 53 87 45 54 100 2
53 65 100 71 113 57 71 100 2
51 61 100 64 94 56 65 100 2
67 79 99 73 91 50 60 99 2
40 52 100 83 95 45 56 100 2
68 79 100 2
79 87 98 79 90 50 60 100 2
65 75 100 90 104 55 67 100 2
47 59 100 78 94 44 57 100 2
34 48 99 75 114 63 74 100 1
53 62 100 62 85 49 58 100 2
79 88 100 80 129 75 88 100 2
41 46 100 63 92 50 60 100 1
72 84 100 66 108 69 79 100 2
59 66 100 68 88 40 52 100 1
76 90 100 78 104 61 72 100 2
62 70 100 85 103 64 74 100 2
66 74 98 97 119 99 105 100 2
79 90 100 50 107 68 76 100 2
57 66 100 68 100 50 61 100 2
69 79 100 61 124 77 54 100 2
74 84 100 66 112 65 76 100 2
74 83 100 90 108 64 76 100 2
74 85 100 64 109 72 80 99 2
59 72 100 89 121 63 77 100 2
55 66 99 66 93 76 79 100 2
77 88 100 81 116 66 79 100 2
61 71 100 63 100 2
83 93 100 89 109 69 79 100 2
63 77 100 47 110 58 70 100 2
47 56 99 84 131 38 57 100 2
46 55 100 58 90 42 54 100 2
70 84 100 102 98 66 74 100 2
62 71 100 66 101 66 72 99 2
60 74 100 83 109 55 68 98 2
55 72 100 68 128 60 77 100 2
65 73 100 84 97 62 70 100 2
44 55 100 68 102 53 65 100 2
50 61 100 76 116 51 66 100 2
73 85 98 76 96 57 67 100 2
51 59 100 75 75 48 54 100 2
61 72 99 89 98 53 64 100 2
49 58 99 72 87 53 61 100 2
81 89 100 80 102 57 67 100 2
41 52 100 65 78 44 52 100 2
38 50 100 56 83 37 49 100 1
70 80 100 86 102 57 67 100 2
40 55 100 67 90 25 39 100 1
59 70 100 68 97 53 63 100 2
66 74 100 65 91 63 69 97 2
55 63 100 69 97 56 63 100 2
53 60 100 74 94 57 67 100 2
73 84 100 60 100 2
87 98 100 69 106 67 77 100 2
55 67 100 61 95 52 63 100 2
79 94 98 82 90 47 57 96 2
43 53 100 64 92 49 58 100 2
57 69 100 81 104 50 63 100 2
71 81 100 63 100 58 67 100 2
74 88 100 94 107 58 70 100 2
78 90 100 99 94 65 72 100 2
87 98 100 63 104 68 78 100 2
48 58 100 56 89 52 61 100 2
59 68 100 75 118 63 76 100 2
47 61 100 67 81 48 56 100 2
59 68 99 79 92 55 64 100 2
59 68 100 41 94 58 47 98 2
54 66 100 51 83 45 54 100 2
83 92 100 102 112 83 89 100 2
44 51 100 76 79 46 53 100 1
48 57 100 62 80 41 50 100 2
54 64 100 63 87 55 61 100 1
42 54 100 64 77 34 44 100 1
56 66 100 77 97 50 60 100 2
57 64 100 72 82 45 54 100 2
46 55 100 92 102 57 72 100 2
74 84 100 81 111 74 83 100 2
95 104 100 81 108 53 66 100 2
70 78 100 88 99 2
85 92 100 69 80 50 57 100 2
57 67 100 79 93 50 61 100 2
70 78 100 87 115 76 85 99 2
101 112 100 60 125 78 90 99 2
93 99 100 76 121 76 87 100 2
65 75 100 57 100 60 70 100 2
68 75 100 55 111 76 84 100 2
76 81 100 95 83 56 62 100 2
60 69 100 91 99 62 71 100 2
52 59 100 60 86 48 57 100 2
57 67 100 64 107 71 80 100 2
64 76 96 123 115 65 76 99 2
46 59 100 63 103 46 59 100 2
58 66 99 71 94 57 65 100 2
60 67 100 71 164 81 92 100 2
61 71 100 68 104 73 80 100 2
61 69 100 80 92 56 65 100 2
54 66 100 76 117 67 78 100 2
56 66 100 81 102 59 68 100 2
45 56 100 83 96 47 57 100 2
62 75 100 46 99 57 66 96 2
59 71 100 76 110 57 67 100 2
66 73 100 73 110 62 71 100 2
67 74 100 59 96 62 70 100 2
56 67 100 70 100 55 66 100 2
47 57 100 77 119 71 83 100 2
45 58 100 109 96 42 54 100 1
70 91 100 78 100 62 75 100 2
78 95 100 63 128 70 83 96 2
70 80 100 80 120 70 80 100 2
55 62 100 86 89 50 59 100 2
48 58 100 73 98 46 58 100 2
70 79 100 66 107 77 83 100 2
73 80 100 61 103 58 67 100 2
67 73 100 70 98 60 69 100 2
60 69 100 77 95 56 66 100 2
68 78 100 112 121 68 80 100 2
59 72 100 70 100 67 74 100 2
42 55 100 66 92 51 60 100 2
44 56 100 63 85 42 52 100 1
58 68 100 61 88 53 61 100 2
61 76 100 62 111 56 67 100 2
54 64 100 67 91 67 71 100 2
49 57 100 41 85 58 64 100 1
92 100 100 75 102 53 63 100 2
54 61 100 61 85 55 61 100 2
56 77 100 72 84 45 54 100 2
53 60 100 67 92 40 53 100 2
53 65 100 61 90 48 55 100 2
56 65 100 51 88 47 57 100 1
57 69 100 68 100 57 67 100 2
48 56 100 69 90 54 63 100 2
48 57 99 68 89 66 71 100 2
44 55 100 49 86 47 56 100 2
86 96 100 89 114 77 85 100 2
64 80 100 67 88 53 61 100 2
86 92 100 85 115 77 87 100 2
69 82 100 94 123 72 83 100 2
72 82 100 92 121 77 87 100 2
drug dose doa fas n2hrs n4hrs iop drug1 dose1
4 2 2 2 2
4 1 2 2 2
1 6 7 2 2 2 2
7 2 2 2 1 1 3
8 2 2 2 2
4 2 2 2 2
1 12 3 2 2 2 2 4
1 5 5 1 2 2 2
5 2 2 2 2
11 2 2 2 2
3 1 2 2 2
1 6 5 1 2 2 1 1,2 2, 0.015
13 2 2 2 2
1 6 6 2 2 2 1 2 0
3 1 2 2 2
1 6 6 2 2 2 1 2 .030
8 2 2 2 2
3 1 2 2 2
4 1 2 2 2
5 2 2 2 2
3 1 2 2 1 2 0.04
7 1 2 2 2
7 2 2 2 2
10 1 2 2 2
4 2 2 2 1 1,2 4,0.04
4 1 2 2 2
1 6 5 2 2 2 1 1 4.5
15 1 2 2 2
4 2 2 2 1 1 4
1 12 20 2 2 2 2
4 2 2 2 1 1,2 2.5,O.O1
8 1 2 2 2
4 1 2 2 1 2 0.03
10 2 2 2 2
1 2 2 2 1 1 1.5
1 6 9 1 2 2 2
5 2 2 2 2
1 6 10 2 2 2 2
4 2 2 2 2
7 2 2 2 2
10 2 2 2 2
1 6 2.5 1 2 2 2
2.5 1 2 2 2
2.5 2 2 2 2
4 2 2 2 2
0.5 2 2 2 1 1 4
3.8 2 2 2 2
3.6 1 2 2 2
7 2 2 2 2
7 1 2 2 2
4 1 2 2 2
7 1 2 2 1 1,2 3.5,.09
2.5 2 2 2 2
5 2 2 2 1 2 .O5
10 1 2 2 1 2 .02
6 2 2 2 2
5 1 2 2 1 1 5
25 2 2 2 2
5 1 2 2 1 1,3 5,75
4 1 2 2 2
8 2 2 2 2
10 2 2 2 2
17 1 2 2 2
10 2 2 2 2
7 2 2 2 2
10 1 2 2 2
20 2 2 2 2
15 1 2 2 2
1 6 25 1 2 2 2
18 2 2 2 2
10 1 2 2 2
4 1 2 2 2
10 2 2 2 2
9 2 2 2 1 1 3
6 1 2 2 2
6 1 2 2 2
5 2 2 2 1 1,2 3,0.075
4 1 2 2 2
4 1 2 2 2
15 2 2 2 2
6 1 2 2 2
5 1 2 2 2
5 1 2 2 2
2 2 2 2 2
3 1 2 2 1 2 0.05
5 2 2 2 2
3 2 2 2 2
8 1 2 2 2
3 2 2 2 2
5 1 2 2 2
3 2 2 2 2
4 2 2 2 1 1,2 4,0.05
6 2 2 2 2
3 2 2 2 2
1.5 1 2 2 2
7 1 2 2 1 3 75
7 1 2 2 1 3 75
4 2 2 2 1 1,2 2,0.03
4 2 2 2 1 3 75
5 2 2 2 1 3 75
30 1 2 2 2
3 2 2 2 2
3 1 2 2 2
10 2 2 2 2
3 1 2 2 2
4 1 2 2 1 1,2 2,0.035
3 2 2 2 2
5 2 2 2 2
1 6 2 1 2 2 2
3 1 2 2 1 2 0.025
9 2 2 2 2
8 2 2 2 2
3 1 2 2 2
9 2 2 2 2
6 2 2 2 1 1 2.5
3.5 1 2 2 2
6 2 2 2 2
7 2 2 2 2
6 2 2 2 2
4 1 2 2 2
6 1 2 2 2
6 2 2 2 1 2 0.04
6 1 2 2 2
20 2 2 2 2
4 1 2 2 2
1 6 7 2 2 2 2
4 1 2 2 2
0 1 2 2 2
7 1 2 2 2
6 2 2 2 2
6 2 2 2 2
3 2 2 2 2
13 1 2 2 2
4 1 2 2 2
2 1 2 2 1 2 0.13
8 2 2 2 2
0 1 2 2 2
13 1 2 2 2
11 2 2 2 2
16 2 2 2 2
8 2 2 2 2
2 2 2 2 1 2 0.05
12 1 2 2 2
4 1 2 2 2
2 2 2 2 2
10 2 2 2 2
3 1 2 2 1 2 0.04
1 1 2 2 2
2 2 2 2 2
7 1 2 2 2
4 1 2 2 2
4 2 2 2 2
3 2 2 2 2
5 2 2 2 1 1,2 2,0.015
1 6 8 2 2 2 2
6 1 2 2 2
5 2 2 2 2
1 6 10 1 2 2 2
3 2 2 2 2
1 6 12 2 2 2 2
3 1 2 2 2
4 1 2 2 2
8 2 2 2 2
5 2 2 2 2
4 2 2 2 2
3 2 2 2 2
5 2 2 2 2
2 1 2 2 2
3 2 2 2 2
9 2 2 2 2
3 2 2 2 2
2 2 2 2 2
5 2 2 2 2
5 2 2 2 2
8 1 2 2 2
7 2 2 2 2
27 1 2 2 2
3 1 2 2 2
1 1 2 2 2
4 2 2 2 2
4 1 2 2 2
14 2 2 2 2
5 2 2 2 2
10 1 2 2 2
15 2 2 2 2
13 2 2 2 2
12 2 2 2 2
5 1 2 2 2
4 1 2 2 2
10 1 2 2 2
1 6 7 2 2 2 2
4 2 2 2 2
1 6 16 1 2 2 2
6 1 2 2 2
8 2 2 2 2
5 2 2 2 2
8 1 2 2 2
4 2 2 2 2
8 2 2 2 2
8 1 2 2 2
1 2 2 2
3 1 2 2 2
7 2 2 2 2
7 2 2 2 2
10 1 2 2 2
15 2 2 2 2
9 2 2 2 2
14 2 2 2 2
7 2 2 2 2
8 1 2 2 2
9 2 2 2 2
3 1 2 2 2
12 2 2 2 2
30 1 2 2 2
1 6 10 2 2 2 2
12 1 2 2 1 1,2 2,0.025
1 6 6 2 2 2 2
1 6 9 2 2 2 2
4 2 2 2 2
15 2 2 2 2
9 2 2 2 2
10 2 2 2 2
5 1 2 2 2
1 2 2 2 1 1,2 3,0.040
3 1 2 2 2
4 2 2 2 2
5 2 2 2 2
1 2 2 2 2
3 1 2 2 2
8 2 2 2 2
7 2 2 2 2
1 2 2 2 1 1,2 2,0.03
5 2 2 2 1 1,2 2,0.15
11 2 2 2 2
30 1 2 2 2
3 1 2 2 2
4 2 2 2 2
1 2 2 1 1 3
0 2 2 2 2
1 2 2 2
10 2 2 2 2
7 2 2 2 1 1,2 3.5,0.05
5 2 2 2 2
7 1 2 2 2
5 2 2 2 2
4 2 1 2 2
3 1 2 2 2
13 2 2 2 2
4 2 2 2 2
15 2 2 2 2
1 6 3 1 2 2 1 1 2
6 2 2 2 2
3 2 2 2 2
3 2 2 2 2
10 2 2 2 2
3 2 2 2 2
8 2 2 2 2
1 1 2 2 2
7 2 2 2 2
5 1 2 2 2
18 1 2 2 2
8 2 2 2 2
7 2 2 2 2
1 6 3 2 2 2 2
13 1 2 2 2
4 2 2 2 2
2 2 2 2 2
1 6 2 2 2 2 2
3 2 2 2 1 2 0.020
25 2 2 2 2
20 2 2 2 2
2 2 2 2 2
3 2 2 2 1 1 2.5
1 6 12 2 2 2 2
3 2 2 2 2
4 1 2 2 2
7 2 2 2 2
2 1 2 2 1 2 0.060
2 1 2 2 2
3 1 2 2 2
3 2 2 1 2
3 2 2 1 1 2 0.060
1 1 2 2 2
pop drug2 dose2 drug3
2 B
2 C
2 A
2 A
2 C
2 B
2 B
2 C
2 A
2 A
2 C
1 2,3 .050,75 B
2 B
2 B
2 A
2 A
2 C
2 C
2 C
2 B
2 C
2 A
2 B
2 A
2 B
2 C
2 A
2 A
2 B
2 A
2 B
2 C
2 C
2 B
2 A
2 C
2 B
2 C
2 C
2 A
2 B
2 A
2 C
2 C
2 B
2 B
2 A
2 C
2 B
2 A
2 A
2 A
2 B
2 C
2 C
2 A
2 A
2 B
1 2 0.050 A
2 C
2 B
2 B
2 C
2 B
2 A
2 C
2 B
2 A
2 C
2 B
2 C
2 A
2 B
2 A
2 A
2 C
2 B
1 2 0.02 C
2 A
2 B
2 C
2 C
2 A
2 B
2 A
2 C
2 B
2 A
2 B
2 C
1 1 5 A
2 C
2 B
2 C
1 1,2 1,0.02 C
2 A
2 A
2 B
2 B
2 A
2 C
2 B
2 A
2 C
2 A
2 C
2 B
2 B
2 A
2 C
2 C
2 B
2 C
2 B
2 A
2 A
2 B
2 B
2 A
2 C
2 A
2 B
2 C
2 B
2 C
2 A
2 A
2 A
2 C
2 C
2 B
2 B
2 C
2 A
2 A
2 B
2 C
2 C
2 A
2 B
2 B
2 B
2 A
2 C
2 B
2 B
2 A
2 A
2 B
2 C
2 C
2 C
2 A
2 A
2 B
2 C
2 B
2 A
2 C
2 B
2 C
2 A
2 A
2 C
2 B
2 A
2 B
2 C
2 C
2 B
2 A
2 B
2 A
2 A
2 C
2 B
2 C
2 C
2 A
2 B
2 C
2 B
2 A
2 A
2 C
2 B
2 B
2 A
2 C
2 A
2 C
2 B
2 A
2 C
2 B
2 B
2 C
2 A
2 B
2 A
2 C
2 A
2 C
2 A
2 C
2 B
2 B
2 A
2 A
2 C
2 B
2 C
2 B
2 C
2 B
2 A
2 A
2 A
2 C
2 B
2 C
2 B
2 C
2 B
2 A
1 1,2 2,0.040 A
2 C
2 B
1 1 4 C
2 A
2 C
2 B
2 B
2 A
2 A
2 A
2 B
2 C
2 B
2 C
2 B
2 A
2 C
2 C
2 B
2 A
2 C
2 B
2 A
2 A
2 C
2 B
2 B
2 C
2 A
2 A
2 B
2 C
2 A
2 C
2 B
2 A
2 A
2 B
2 C
2 C
2 B
2 B
2 C
2 A
2 C
2 B
2 A
2 B
2 A
2 A
2 B
2 C
2 C
2 A
2 B
2 B
2 A
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